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ABSTRACT 
 
Loss of large segments of bone creates critical size defects (CSDs). These fail to heal 
spontaneously and present major clinical challenges to orthopaedic surgeons. The 
research described in this thesis is based upon the hypothesis that the healing of 
CSDs is responsive to the ambient mechanical environment, and can be accelerated 
by mechanical modulation. This hypothesis was tested in rat, femoral CSDs treated 
with recombinant, human, bone morphogenetic protein-2. 
 
For this study I designed novel external fixators allowing experimental control over 
the local mechanical environment. These were characterised by extensive 
mechanical testing prior to evaluation in the rat model.  
 
Low stiffness fixators induced callus formation 9 days after surgery, whereas rigid 
fixation delayed it until 2 weeks. All defects were radiologically bridged after 3 
weeks. Rats were euthanised after 8 weeks and the defects evaluated by a battery of 
imaging, mechanical and histological tests. All confirmed the superiority of the 
lowest stiffness fixators. 
 
Based upon these data, I hypothesised that healing would be improved by imposing 
low stiffness for the first two weeks of healing, followed by high stiffness for the 
remaining six weeks. The experimental data confirm that this regimen dramatically 
accelerated callus formation and maturation, and induced faster remodelling of 
endosteal and periosteal callus. This was associated with higher failure strength, 
fewer trabeculae, decreased callus size and thicker and more uniform distribution of 
new cortical bone. Histologically it was not possible to detect cartilage within the 
defects prior to the appearance of bone, suggesting that healing either does not occur 
through endochondral ossification, or that this process is very rapid. 
 
These data confirm that the healing of CSDs is highly responsive to the ambient 
mechanical environment, allowing the rate and quality of healing to be manipulated. 
This information will help develop more efficient ways to heal CSD clinically.
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1.1 THE STRUCTURE AND FUNCTION OF BONE  
 
The functions of bone are classified as mechanical, mineral storage, and 
haematopoietic [1]. The mechanical functions of bone include protection for the 
brain, spinal cord, and chest organs, while providing rigid support for the limbs. The 
skeletal system provides rigid kinematic links (joints) and muscle attachment sites 
that facilitate muscle action and bodily movement. Bone is also the principal 
reservoir for calcium, but additionally stores other ions such as phosphate, sodium 
and magnesium. Bone also serves as host for the haematopoietic bone marrow. 
Despite its inert appearance, it is one of the most dynamic and metabolically active 
tissues in the body.  
 
The mechanical properties of bone are related to its construction and internal 
architecture. Bone is among the body’s hardest tissues, only dentin and enamel in the 
teeth being harder. Although extremely light, bone has high tensile strength. This 
combination of strength and light weight is a result of its hollow tubular shape, the 
layering of bone tissue and the internal support of the matrix. 
 
Because bone is able to remodel and repair, it can adapt its mass, shape, and 
properties to changes in its mechanical environment and normally endures voluntary 
physical activity for life without breaking or causing pain.  
 
A typical long bone (e.g. tibia, femur) consists of a central cylindrical shaft, the 
diaphysis, and two wider and rounded ends, the epiphyses (Figure 1. 1). A 
metaphysis connects the diaphysis with each epiphysis. In growing mammals, the 
growth plate, located in between the epiphysis and metaphysis, ensures continuous 
growth, enlarging the bone while maintaining its shape [1]. 
 
The outer surface of bone is covered by the periosteum, a sheet of fibrous connective 
tissue with an inner cellular or cambium layer of undifferentiated cells. The 
periosteum has a potential to form bone during growth and fracture healing. The 
marrow cavity in the diaphysis of cortical and cancellous bone is lined with a thin 
cellular layer called the endosteum. The endosteum (an internal periosteum) is a 
membrane of bone surface cells: osteoclasts, osteoblasts and bone lining cells. 
                         
Chapter One 
 
 
 23 
                                
 
Figure 1.1 Basic structure of a typical long bone, the femur [2]. 
 
Two types of bone can be distinguished in the human skeleton: cortical and 
cancellous (Figure 1.1). Cortical bone is a dense, solid mass with only microscopic 
channels. Approximately 80% of the skeletal mass in the adult human skeletal is 
cortical bone, which forms the outer wall of all bones and is largely responsible for 
the supportive and protective function of the skeleton. The bulk of cortical bone is in 
the shaft of long bones in the appendicular skeleton. The remaining 20% of the bone 
mass is cancellous bone, a lattice of large plates and rods known as trabeculae, found 
in the inner parts of the bone. Cortical and cancellous bone have a different 
distribution throughout the skeleton and differ in their development, architecture, 
function, proximity to the bone marrow, blood supply, rapidity of turnover time, and 
magnitude of age-dependent changes and fractures. Cortical bone is stiffer than the 
cancellous bone. 
  
Cancellous bone is found in many places in bone. It useful to mention five locations: 
at the ends of long bones, under synovial joints; within short bones; within flat 
bones; under protuberances to which tendons attach; and in the medullary cavity of 
some long bones. Short and flat bones are completely filled with cancellous bone. 
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The mechanical properties of cancellous bone are a function of variation in the 
material’s apparent density and also of the arrangement of the bony trabeculae with 
respect to the loading direction. The arrangment of trabecular bone is not random, 
but there is no convincing theory that explains this distribution. One hypothesis is 
that the distribution of the trabecular bone is mainly related by the direction of the 
principal stresses arranged so that they will not be subjected to significant bending 
moments, which minimizes the stress they experience (Wolff’s Law). However, a 
completely different approach suggests that the observed structure is adaptive. This 
considers cancellous bone structures to be minimum weight braced frameworks. A 
structure in which load is resisted by changes in length of its members (trabecular 
struts), rather than by bending, is known as a braced network. They are orthogonal 
nets and depending on the loading system they may be rectangular or, in systems 
with concentrated loads, they are developments of equiangular spirals. Furthermore, 
Hert and his co-workers [3] refuse to believe the idea that trabecular struts in the 
long bones are organized in the direction of principal stresses. They suggest that the 
struts are oriented to resist the compressive stresses at the extremes of the joint 
motion. All in all the architecture of bones is arranged so that they can carry out their 
functions and yet be as light as possible and of appropriate stiffness.   
 
Bone consists of 65% mineral and 35% organic matrix, cells and water. The bone 
mineral, which is largely impure hydroxyapatite, is in the form of small crystals 
deposited between collagen fibers. The organic matrix consists of 90% collagen, 
predominantly types I, but with small amounts of collagen V and III and about 10% 
of various noncollagenous proteins, the most abundant ones being osteocalcin, 
osteonectin, osteopontin and bone sialoprotein [1]. 
 
The mechanical properties of bone are dependent on the type of bone, loading 
direction and the rate of loading. Typical stress-strain curves for uniaxial, monotonic 
tension and compression loading of cortical bone, both in longitudinal and transverse 
directions, show that cortical bone is stonger in compression than in tension. For 
example, the tensile strength in longitudinal loading is aproximataly 130(MPa), 
while in the corresponding compressive strength is 190(MPa). For transvere loading, 
the tensile strengh is very low, 50MPa, while the compressive strength is 130(MPa) 
and comparable to the tensile strengh in longitudinal direction. This suggests that 
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cortical bone has adapted to a situation where compressive loading is greater than 
tensile. This is also consistent with the combined bending and axial compressive 
loads that are acting on the femoral diaphysis during everyday activities such as 
walking. 
 
The major cellular elements of bone are osteoblasts, osteoclasts, and osteocytes. 
Osteoblasts are mesenchymal cells that synthesise and mineralize the bone matrix. 
They are derived from mesenchymal progenitor cells found in marrow, periosteum 
and certain other tissues; they are often termed Mesenchymal Stem Cells (MSCs). 
Whether these are true stem cells remains controversial, so they are sometimes 
termed Mesenchymal Stromal Cells. As a result, while preserving the acronym, the 
abbreviation MSC is used throughout this thesis to denote a pleuripotent, 
mesenchymal osteoprogenitor cell without taking a position on their stemness. The 
main stages of osteogenic differentiation are shown in figure 1.2. 
                                                       
 
 
 
Figure 1.2 Key stages in the differentiation of MSCs into osteoblasts. 
 
 
Exposure of MSCs to an osteogenic bone morphogenetic protein (BMP) leads to the 
rapid phosphorylation of SMADs (Proteins that are homologs of the drosophila 
protein, mothers against decapentaplegic (MAD) and the Caenorhabditis elegans 
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protein SMA. The name is a combination of the two.), which migrate to the nucleus 
and trigger the expression of a cascade of genes associated with osteogenesis. 
Alkaline phosphatase is expressed in pre-osteoblasts as an early marker of 
osteogenesis. Osteocalcin, a late marker, is expressed by osteoblasts with the ability 
to deposit a mineralized matrix. Under in-vitro conditions, the process of 
osteogenesis takes about 25 days. (Figure 1.2) 
 
Osteoclasts, which degrade the matrix of bone, are derived from haematopoietic 
stem cells in the bone marrow. As depicted in figure 1.3, osteoclastogenesis is 
coupled to osteoblastogenesis through interactions between RANK (Receptor 
Activator of NF−κB) on the surface of pre-osteoclasts, and RANK ligand (RANKL) 
on the surface of osteoblasts.  This interaction stimulates osteoclastogenesis. A 
soluble form of RANK known as osteoprotegerin (OPG) inhibits the binding of 
RANK to RANKL and thus acts to inhibit osteoclastogenesis. During the final stage 
of osteoclastogenesis, cells fuse to form large multinucleated osteoclasts with the 
ability to resorb bone. 
 
                               
                      
Figure 1.3 Key steps in the differentiation of haematopoietic stem cells into osteoclasts and 
its coordinate regulation with osteoblastsgenesis via RANK-RANKL interaction [4] 
 
 
Osteocytes are derived from osteoblasts that became embedded in the matrix that 
they synthesized, and function as mechanosensors. Each osteocyte occupies a space, 
or lacuna, within the matrix and extends filopodial processes through canaliculi in 
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the matrix to contact processes of adjacent cells by means of gap junctions. Because 
the diffusion of nutrients and metabolites through the mineralized matrix is limited, 
filopodial connections permit communication between neighbouring osteocytes, 
internal and external surfaces of bone, and with blood vessels traversing the matrix. 
 
Osteocytes within the mineralized matrix are in direct communication with each 
other and surface osteoblasts through their cellular processes. The primary function 
of the osteoblast (or lining cell) - osteocyte continuum is considered to be 
mechanosensory, to transduce stress signals such as stretching and bending into 
biological activity [5-7]. The flow of extracellular fluids in response to mechanical 
forces throughout the canaliculi induces a spectrum of cellular responses in 
osteocytes. Rapid fluxes of bone calcium across these junctions are thought to 
facilitate transmission of information between osteoblasts on the bone surface and 
osteocytes within the structure of bone itself. This mechanism is thought to be 
involved in the detection of microdamage, and responses to the level and distribution 
of strain within bone tissue that influences adaptive modelling and remodelling 
behaviour [8]. At any sites in response to signals which are poorly understood, bone 
is constantly turning over through the coordinated activities of osteoblasts and 
osteoclasts (Figure 1.4). 
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Figure 1.4 Key events in the remodelling of bone. Bone is constantly remodelling. 
Osteoclasts adhere to the surface of bone and form a resorption pit. Osteoblasts then enter 
the site and synthesise new bone. They subsequently become embedded in mineral and 
differentiate into osteocytes [9]. 
 
 
1.2 BONE REGENERATION AND REPAIR 
 
Bone is one of the few organs in the body that heals without scarring. The biology of 
fracture repair involves a true regeneration of the adult tissue rather than healing and 
production of a surrogate material. The molecular events that govern fracture healing 
are a complex network of signals signifying tissue damage, cell death, cell 
recruitment, cell proliferation, cell differentiation and tissue formation. The phases 
of fracture healing can be summarized as: hematoma formation (early fracture), 
inflammation, reparative phase and remodelling phase (Figure 1.5).        
 
                 
 
Figure 1.5 Main phases in fracture healing: A) Early fracture - haematoma phase; B) 
Inflammatory phase – initiation of fracture healing and the associated cascade of cellular 
responses; C) Reparative phase - cartilage formation and calcification, calcified cartilaginous 
tissue replaced with woven bone; D) Remodeling phase - woven bone remodels into mature 
lamellar bone [10]. 
 
These phases involve the coordinated activity of different cell populations that 
proliferate, differentiate and synthesize extracellular matrix components. During the 
inflammatory phase, the periosteum of bone lifts, and a haematoma is formed 
between the bone ends due to the rupture of blood vessels. This haematoma releases 
a large number of signalling molecules, including inflammatory cytokines such as 
interleukin-1 (IL-1) and interleukin-6 (IL-6) and growth factors such as platelet-
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derived growth factor (PDGF), insulin-like growth factors (IGFs) and members of 
the transforming growth factor-β (TGF-β) superfamily, including BMPs. BMPs are 
low-molecular-weight homodimeric proteins whose sub-units are linked by a 
disulfide bond. BMP-2, used throughout the work described in this thesis, has a 
moleculr weight of 26kDa. BMP-2 signals through two types of transmembrane, 
serine/threonine kinase cell receptors, BMPRI and BMPRII. Binding of BMP-2 to its 
receptors results in the phosphorylation of BMPRI by BMPRII and, subsequently, 
Smad-1, Smad-5, and Smad-8 which form a complex with Smad-4 within the cell 
nucleus. This complex activates the expression of BMP target genes, which 
ultimately results in cartilage and bone formation. The intracellular process is 
regulated by the inhibitory function of Smad-6 and Smad-7, which turn off BMP 
signaling by preventing the phosphorylation of Smad-5. The actions of BMPs are 
constrained by a number of inhibitory moecules, including noggin, chordin and DAN 
(Figure 1.6). These factors appear to regulate the initiation of fracture healing and 
the associated cellular response.  
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Figure 1.6 BMP receptor and signalling cascade. BMPs contact with type I and type II BMP 
receptors (BMPR). BMPR-II phosphorylates BMPR-I, which forms the transducing complex 
and phosphorylates Smad-1, Smad-5 and Smad-8. Smad-1 and Smad-5 interact with Smad-4 
enter the nucleus and initiate the BMP response genes. Smad-6 and Smad-7 inhibit 
phosphorylation of Smad-5. Noggin, chordin, and DAN are BMP antagonists and prevent 
receptor binding. (Adapted from Reddi AH. Bone Morphogenetic Proteins: from basic 
science to clinical applications. JBJS Am 2001; 83:S1-3) 
 
 
MSCs enter the defect to initiate repair. The source of these cells is unclear; possible 
sources include the inner cambial layer of the perisoteum, the endosteum, the bone 
marrow, the surrounding musculature and the vascular endothelium. In addition, 
there is recent evidence of circulating osteoprogenitor cells [11]. The MSCs 
differentiate into chondrocytes and osteoblasts, which will form bone via 
endochondral and intramembranous ossification, respectively.  
 
Intramembranous ossification forms bone directly from osteoprogenitor cells, 
according to the schema shown in figure 1.2, without first forming cartilage to create 
hard callus. Endochondral ossification, in contrast, involves the differentiation of 
MSCs into chondrocytes, which form a cartilaginous intermediate that becomes 
calcified and eventually replaced by bone. This type of fracture healing is attributed 
to the adjacent periosteum and provides an early, bridging, soft callus. 
Mineralization of the cartilage involves a mechanism similar to long bone growth at 
the growth plate and requires reestablishment of the vascular and nutrient supply. 
Chondrocytes hypertrophy and undergo apoptosis, the extracellular matrix calcifies 
and blood vessels penetrate the matrix. The calcified cartilage is resorbed and 
replaced by immature, woven bone formed by osteoblasts. In the final healing phase, 
osteonal remodelling of the newly formed bone tissue and of the fracture ends 
restores the original shape and mature lamellar structure of the bone. This last phase 
of bone healing can take from months to years to complete.  
 
 
1.3 CURRENT CLINICAL MANAGEMENT OF LARGE SEGMENTAL 
DEFECTS  
  
It is estimated that in the UK alone about 1.6 million bone fractures occur annually, 
and 10-20% of those fractures result in impared, delayed or non-unions. This is 
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associated with economic cost in lost productivity, time off work and morbidity. 
Although fractures normally heal in the manner described in the previous section, 
large segmental defects do not. Indeed, once a segmental defect reaches a certain 
critical size it is too large to heal naturally. While only 5 to 10% of all fractures are 
critical size defects, they are a serious clinical problem that requires surgical 
intervention. Most common causes of such defects are related to trauma from car 
accidents, sports activities etc.; other causes are tumour resection and failed 
arthroplasty.  
 
Autografting is the method of choice for treating large segmental defects in long 
bones. In this procedure, autologous bone is surgically recovered from the iliac crest 
of the patient and transferred to the site of the non-healing osseous lesion. Although 
successful, this procedure is constrained by the limited amount of autologous 
material that is available for autografting and by morbidity associated with this 
invasive procedure. Allografting addresses some of these issues. 
 
Allograft bone is recovered from cadavers and processed to remove pathogens and 
immunogens. It is readily available in large amounts and, of course, its harvest 
imposes no morbidity upon the donor. However, it is essentially dead bone. 
Although, it provides mechanical support and can function as space filler, it cannot 
undergo remodelling and it has a high failure rate when implanted into load bearing 
environments. 
 
As an alternative to allograft material, there are a number of synthetic bone 
substitutes, many of which are based upon calcium phosphate either alone or in 
conjunction with an organic phase, such as collagen. In general, these are not 
clinically superior to allograft. Calcium phosphate is available in a variety of forms 
and products including powders, ceramics and cements. These substitutes are 
osteoconductive, which means that there is an ingrowth of sprouting capillaries, 
perivascular mesenchymal tissues, and osteoprogenitor cells from the recipient host 
bed into the three-dimensional stucture of an implant or graft. But they are not 
osteoinductive, and this is a phenomenon in which there is a mitogenesis of 
undifferentiated perivascular mesenchymal cells leading to thee formation of 
osteoprogenitor cells with the capacity to form new bone, unless growth factors or 
Chapter One 
 
 
 32 
other osteoinductive substances are added to create a composite graft. They do not 
provide a high level of structural support because they are brittle and have little 
tensile strength. They increase bone formation by providing osteoconductive matrix 
for host osteogenic cells. The disadvantages with such materials encountered 
clinically include: low or unpredictable resorption, difficultly in handling and poor 
clinical results with occasional inflammatory foreign body reactions.  
 
Distraction osteogenesis provides another option for treating segmental bone defects. 
Commonly called the Ilizarov teqnique, it has gained a great deal of popularity since 
its introduction in the West 20 years ago. Professor Gavril A. Ilizarov [12, 13] 
invented this procedure in 1951 in Siberia for limb salvaging and lengthening 
procedures. This is a specialized form of external fixation, also known as ring or 
circular external fixator (Figure 1.7).  
                            
 
 
Figure 1.7 Circular external fixator used for the Ilizarov technique [14].  
 
These devices utilize Ilizarov’s theory of controlled distraction histogenesis, 
whereby bone is fractured, but only involves cortex leaving medullary vessels and 
periosteum intact, in the metaphyseal region and slowly lengthened. This distraction 
process allows for bone reconstruction within the segmental defects through the 
insertion of small Kirschner wires (K-wires) under tension and circumferential ring 
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supports. As new bone growth occurs in the metaphyseal region, it pushes a segment 
of healthy bone into the defect. The tension that is created by gradual distraction 
stimulates the formation of new bone, skin, blood vessels, peripheral nerves and 
muscle. Bone lengthening can occur at a rate of approximately one centimetre per 
month.  
 
The advantages of these circular fixators are that they permit stabilization of 
fractures with minimal operative trauma to soft tissues, while preserving critical 
blood supply. They allow early use of the limb, including weight bearing. The 
Ilizarov technique eliminates the need for extensive soft tissue procedures and bone 
grafting. Angulatory, translation, rotational, and length deformities can be corrected, 
and union can be obtained simultaneously in many of these difficult situations.  
 
However, there are also disadvantages associated with the use of these devices. The 
most commonly reported complication is pin-track infections, but most can be 
prevented with good pin care and local antibiotics. Pain is also common and can be 
severe to a patient, but is treatable with analgesics. The technique is labor-intensive 
and requires an extended period of treatment in the device. Due to limited range of 
movement and cosmetic appearance this technique is not favored by patients.  
Although for some surgeons it became a method of choice in dealing with large 
segmental bone defects, the propensity for complications and the length of treatment 
have limited its universal endorsement.  
 
In recent years, clinicians have been able to use rhBMP-2 (Infuse™) and rhBMP-7 
(Osteogenic protein-1; OP-1™) to enhance bone healing. These proteins are 
surgically implanted on a scaffold into sites requiring an osteogenic stimulus. Infuse 
is approved by the Food and Drug Administration (FDA) for the use in the specific 
situation of a single level anterior lumbar spine fusion between L4 and S1 as a 
substitute for autogenous bone graft in adults with degenerative disc disease who 
have had at least six months of nonoperative treatment for this condition. It is also 
approved for the treatment of acute tibial fractures in adults as an adjunct to standard 
care using open fracture reduction and intramedullary (IM) nail fixation. OP-1 was 
approved for the treatment of tibial nonunions of at least 9 months duration, 
secondary to trauma in the skeletally mature patients, in cases where previous 
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treatment with autograft has failed or use of autograft is unfeasible. Despite this, 
most use of BMPs in the clinic is “off-label”, which means its not approved by the 
FDA. 
 
Pre-clinical studies in goat tibia, rabbit ulna and rat femur showed that BMPs were 
able to accelerate and enhance bone healing by as much as 30-40% in CSDs [15-21]. 
In contrast to the rich literature concerning animal models of bone healing, there are 
only a few serious clinical studies in humans that looked at the effects of  BMPs on 
the healing of human long bones, although clinical studies treating spinal fusions 
with BMPs are more extensive [22-30].  
Studies to investigate the effects of BMPs on human long bone healing have 
concentrated on open tibial fractures, a condition that is known to be associated with 
complications, particularly non-unions. Govender et al. [31] in a prospective, 
randomized, controlled, single blinded study evaluated the safety and efficacy of 
rhBMP-2 in the accelerated healing of open tibial shaft fractures. The study was 
divided into three groups: 1) intramedullary nail fixation and routine soft tissue 
management; 2) standard of care and an implant containing 0.75 mg/mL of rhBMP-
2; 3) standard of care and an implant containing 1.50 mg/mL of rhBMP-2. The 
rhBMP-2 was applied to a resorbable collagen sponge and placed over the fracture at 
the wound closure. The investigators reported that use of rhBMP-2 implant was safe 
at the dose 1.50 mg/mL and, compared to the standard of care, was associated with 
accelerated bone healing, a reduction in infection rates, less bone grafting and a 
reduced frequency of secondary interventions from 46 to 26%. Another study by 
Swiontkowski et al. [32] reported analysis in a group of patients with severe open 
tibial fractures treated either with intramedullary nail fixation and routine soft tissue 
management, or rhBMP-2 1.50 mg/mL absorbed into a resorbable collagen sponge. 
They found that by adding the rhBMP-2 implant, the frequency of bone-grafting 
procedures and other secondary interventions was significantly reduced.  They also 
found that patients in the rhBMP-2 group achieved weight bearing an average of 
thirty-two days sooner than the control group. A study by Jones et al. [33] used 
rhBMP2/allograft in the treatment of diaphyseal tibial fractures associated with 
cortical defects. They suggested that rhBMP-2/allograft was a safe and effective 
alternative to autogenous bone grafting.  
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Despite these promising findings, most orthopaedic surgeons who use BMP-2 and 
BMP-7 are of the opinion that, although these molecules are helpful, they provide 
only incremental improvement over existing methods. It is unclear why their 
performance in humans is inferior to that in experimental animals. One possibility, 
which forms the basis of this thesis, is that insufficient attention has been given to 
the mechanical environment within which these molecules are expected to perform. 
 
 
1.4 THE INFLUENCE OF MECHANICAL FORCES ON BONE HEALING 
 
It is well known that the biomechanical environment plays a key role in maintaining, 
repairing and remodelling bone, thus enabling it to meet its functional demands. 
Bone adaptation is an important and illustrative example of this. In the 1890s Julius 
Wolff was one of the pioneers who used his clinical and experimental morphologic 
observations to develop two concepts, which are today known as Wolff’s Law. 
Wolff stated that skeletal elements are strategically placed to optimize strength in 
relation to the distribution of applied loading and that the mass of the skeletal 
elements is directly related to the magnitude of the applied loads. Wolff’s Law 
regards the trabeculae of cancellous bone as embodying the stress trajectories 
determined from the stress analysis of a homogeneous and continuous elastic object 
of the same shape as the bone and loaded in the same way. However, stress 
trajectories and the trabecular architecture cannot be related to one another in the 
manner suggested by Wolff’s Law. For this continuum model it is assumed that bone 
is linearly elastic, homogeneous and isotropic while it is well known that the real 
cancellous bone architecture neither homogeneous nor isotropic. This observation is 
only one of the 20 objections scientists have raised over the years regarding Wolff’s 
Law. Nevertheless the basic tenets of Wolff’s Law are generally accepted and 
scientists today agree that fractures will repair and remodel depending on the loading 
conditions [8, 34, 35]. 
 
After skeletal maturation bone continues to remodel throughout life (Figure 1.4) and 
to adapt its material properties to meet the mechanical demands placed upon it. The 
cellular and molecular mechanisms by which bone responds to mechanical stresses 
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are not well understood. Therefore, it has been a goal of many investigators to 
understand better the relationship between biomechanical factors and cellular 
responses involved in normal and impaired bone fracture healing.  
 
Much of our present day understanding about the effects of mechanical forces on 
tissue differentiation comes from Friedrich Pauwels. Pauwels [36] was one of the 
first to recognize that physical factors cause stress and deformation of what we now 
refer to as MSCs, and that such mechanical stimuli could determine the cell 
differentiation pathway. By using simple experimental models he developed these 
general concepts and demonstrated how shear stress (also called distortional stress) 
causes tissues (cells) to change shape, but not volume, whereas hydrostatic stress 
results in change of volume, but not of shape (Figure 1.8).  
     
        
Figure 1.8 Pauwel’s concept of tissue differentiation: a schematic representation of the 
hypothesised influence of the biophysical stimuli on tissue phenotype. Deformation of shape 
strain is on the x axis and the hydrostatic compression is on the y axis. A combination of 
these stimuli will act on the MSCs leading to hyaline cartilage, fibrocartilage, or fibrous 
connective tissue as shown on the perimeter of quadrant. Depending on the response of the 
mechanical environment to the presence of these tissues, osteoblast proliferation and 
ossification can occur. However, bone regeneration occurs only after stabilization of the 
mechanical environment by the formation of soft tissue. (From Weinans and Predergast, 
1996)  
 
Roux [37] was first to explore the relationship between mechanical stimuli on cells 
and tissue adaptation. He proposed that cells within tissues engage in “a competition 
for the functional stimulus” and that this competition determines cell survivorship 
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and therefore tissue phenotype. He hypothesized that the mechanical environment 
has the following relationship to phenotype: tension forms fibrous connective tissue, 
shearing forms cartilage, and compression forms bone. He postulated that structural 
adaptation of tissue to mechanical loads is a direct consequence of competition 
between the tissue cells. Pauwels [36] compared the mechanical environment on 
cells in a fracture callus with fracture repair patterns, and proposed that deformation 
(strain) of shape is a specific stimulus for the formation of collagenous fibrers and 
hydrostatic compression is the specific stimulus for the formation of cartilaginous 
tissue. Osteogenesis however requires that the mechanical environment first becomes 
stabilized by the presence of fibrous tissue, a concept also embraced by Perren. 
Therefore, Pauwels’ hypothesis as shown in the Figure 1.7 is that the ambient 
mechanical environment determines tissue phenotype. Carter [38] developed this 
concept as a function of shear and hydrostatic stress called the osteogenic index. 
 
Another important mechanical factor is intrafragmentary strain. When the fractured 
bone is loaded, the fracture fragments displace relative to each other. This strain 
produced in the fracture gap is named “Intrafragmentary Strain” (IFS), a concept 
first introduced by Perren [39]. Although intrafragmentary strain theory is very 
useful for understanding the relationship between motion and bone healing process, 
the theory is not a general theory of bone regeneration, because the strain field in the 
fracture gap is multiaxial and mechanical stimuli vary spatially throughout the 
fracture callus [39].  
 
Despite this, through observational and to a lesser extent, empirical study, several 
theories have been developed on the role of mechanical stimuli or intrafragmentary 
movement in governing the differentiation of MSCs into bone, cartilage, fibro-
cartilage and fibrous tissue. There are four main factors that influence IFS: the 
rigidity of the technique used to stabilize the fracture, the surface area of the fracture 
fragments, gravitational loads and muscular loads. The strain is defined as the 
relative motion over the surface area at the fracture site. In this way, comminuted 
fractures can tolerate relatively greater motion, since the strain is applied over a 
larger surface area of fracture fragments. If IFS exceeds a critical level, the blood 
supply for healing at the fracture site is subjected to repeated trauma and cannot 
become established. Moreover, instability prevents the production of stable tissues at 
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the fracture site. Fibrous tissue is relatively resistant to high stress forces, while 
cartilage and bone cannot form under conditions of high strain [38, 40]. As long as 
high strain forces exist at a fracture site (i.e. stability is inadequate), fibrous tissue 
will remain and stabilizing bony callus will be unable to form. If such conditions 
continue for long enough, a fibrous non-union will result.  
 
Local tissue stress and strains not only alter the pressure on the bone cells, but also 
influence cell differentiation [41]. In the mechanically loaded fracture gap after 
fixation, hydrostatic pressure is relatively low and IFSs are relatively high. However 
when callus grows the stiffness in the fracture increases. Rising hydrostatic pressure 
decreases matrix permeability while fracture shear strains decline. In this 
environment, increasing numbers of chondrocytes are formed and endochodral 
ossification begins. As more collagen matrix is produced the strain declines further, 
more osteoblasts accumulate and ossification predominates. It is plausible that MSCs 
cannot differentiate into bone cells or chondrocytes unless a suitable biophysical 
environment for tissue differentiation is present. Therefore, for bone healing to occur 
the fracture environment has to be exposed to the strain rates that elicit bridging 
callus, increasing collagen synthesis and rising hydrostatic pressures. 
 
 
1.5 CRITICAL SIZE SEGMENTAL DEFECTS  
  
1.5.1. Introduction  
 
Most of the literature on the biology and biomechanics of bone healing, discussed 
above, pertains to the behaviour of fractures or osteotomies that are small enough to 
heal spontaneously. Relatively little attention has been paid to large segmental 
defects in bone which are unable to heal spontaneously (Figure 1.9).  
 
The concept of a critical size defect (CSD) was introduced by Schmitz and Hollinger 
[42]. Although it was originally used in the context of craniomandibulofacial 
nonunions, it is also used for non-healing segmental defects in long bones, and 
elsewhere. The reason why CSDs do not heal is unknown. Fracture healing has three 
major requirements: osteoprogenitor cells, a scaffold and an osteogenic stimulus. 
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Assuming that these requirements also hold true for CSDs, it is possible to speculate 
that one or more of these are absent from the CSD.  
 
Under natural conditions a CSD fills with a haematoma, a large part of which is a 
fibrin scaffold. The absence of a scaffold is thus unlikely to account for the inability 
of CSDs to heal, a conclusion reinforced in the present research, where the 
implantation of a collagen scaffold into a rat CSD did not result in healing. 
 
The literature contains several reports of healing following the introduction of MSCs 
into experimental CSDs in laboratory animals [43] and human patients [44]. This 
suggests a lack of osteoprogenitor cells in CSDs. In laboratory animals, this may 
reflect the absence of periosteum, which is usually removed during the surgical 
creation of the defect. In human patients, this may reflect soft tissue damage due to 
trauma or surgical resection.  Experimental CSDs created in laboratory animals 
usually heal in response to an osteoinductive stimulus, such as BMP-2, suggesting 
that such factors are also limiting in CSDs. 
 
The data presented in Chapter 5 of this thesis provide further insight and suggest that 
the reparative cells are derived from periosteum on the cut ends of the bone adjacent 
to the CSD. BMP-2 seems to have a chemotactic effect, resulting in the migration of 
cells across the collagen scaffold, and an osteogenic effect, once the cells have 
traversed the defect. These observations suggest that, at least in this rat model, an 
untreated CSD fails to heal because osteoprogenitor cells adjacent to the defect are 
unable to traverse the lesion. 
 
In this thesis, I study the effects of the mechanical environment on the healing of 
CSDs in rats. It is an attractive topic, because I have been unable to identify any 
refereed research papers on the influence of the mechanical environment in-vivo on 
the healing of CSDs. The judgment of orthopaedic surgeons, based upon clinical 
experience, is that rigid fixation favours better healing, but this remains to be 
demonstrated in controlled studies. Current clinical options for treating large 
segmental defects were described in section 1.3. 
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Figure 1.9 A radiographic image showing critical sized segmental defect in the mid section 
of human tibia stabilized by an external fixator treated with rhBMP-2 2 weeks post surgery 
[2]. 
 
Therefore, the primary goal of these studies is, using a rat femoral defect model, to 
investigate the role of the mechanical environment on the healing of CSDs enhanced 
by rhBMP-2 treatment in long bones.  
 
 
1.5.2. BMP-2 and the healing of critical size defects in the rat femur 
 
Although rhBMP-2 is used clinically to treat critical sized osseous defects, this is an 
off-label use for which there is no strong evidential support. Many bone fracture 
healing studies in-vivo illustrate the bone-inducing properties of several different 
BMPs in laboratory animals. Experiments in animals and humans have confirmed 
the osteoinductive activity of these proteins by demonstrating new formation of bone 
in ectopic and orthotopic sites. For example, rhBMP-2 absorbed onto demineralized 
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bone matrix or a collagen gel and implanted subcutaneously in rats was able to 
induce bone and cartilage formation [45-47]. Many of the preclinical long bone 
studies have used CSDs that will not bridge or heal without the addition of an 
osteoinductive or osteoconductive substances. Implantation of BMP-2 and BMP-7 in 
a rabbit ulnar model results in bone induction throughout the defects and bony 
healing as assessed by radiography and histology [48, 49]. Larger animal studies 
have also supported the ability of BMPs to heal large segmental defects. For 
example, rhBMP-2 has shown the ability to heal large defects in canine radii and 
sheep femora [50, 51]. In addition, healing of large segmental defects in a canine 
long bone ulna model, as well as in the ulnae and the tibiae of African Green 
monkeys, was accomplished by the application of rhBMP-7 and bone matrix 
particles [49, 52, 53]. 
 
Several studies have investigated bone formation in response to BMPs in the rat 
femoral defect model, using BMP-2 gene transfer [54-57] or delivery of recombinant 
BMP-2 [58-61]. In general, these studies confirm the ability of recombinant BMPs to 
enhance de novo bone formation in the critical sized defects. Results from prior 
studies conducted in this laboratory agree with this general conclusion, but our 
results have also detected inconsistencies. The new formed bone has poor quality of 
bone architecture, insufficient mechanical properties and high inter-animal 
variability. The project reported in this thesis has its origins in our desire to 
understand the basis of this variability and thereby to provide a remedy. 
 
For the past decade members of our laboratory have studied a rat femoral defect 
model, originally developed by Einhorn and colleagues [62]. Initially we ascribed 
the variability of the healing response elicited by BMP-2 to problems associated with 
its delivery. When BMP-2 is absorbed into a collagen sponge and placed into a 
defect in-vivo, most of the BMP-2 is rapidly released and is essentially gone after a 
few days. This contrasts with natural bone healing where there is a sustained 
presence of BMPs. To overcome the delivery problem, we transferred BMP-2 cDNA 
using a recombinant adenovirus vector. However, gene transfer was no better than 
rhBMP-2 in repairing the segmental defects, despite providing an endogenous source 
of BMP-2 for several weeks. With both gene and protein delivery, we found residual 
cartilage within the defects of many rats, suggesting that healing is not complete by 
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the end of the 8 week experiment. This conclusion is supported by the results of 
mechanical testing, which revealed that the torsional strength and stiffness of the 
newly formed bone reached only approximately 25% of the intact contralateral bone. 
Moreover, there was high animal to animal variability [54]. This led me to consider 
more closely the possibility that mechanical factors were involved, especially as we 
used a very stiff external fixator in this rat model and I observed cortical thinning in 
the area facing the fixator. For this reason, I designed novel external fixators whose 
stiffnesses could be adjusted to control the mechanical environment of the segmental 
defect. 
 
  
1.5.3. Influence of external fixator properties on fracture healing 
 
Although there are no experimental data on the effects of mechanical forces on the 
healing of segmental defects, many computational models have been developed to 
study the effect of the mechanical environment on fracture healing. They all found 
that the stiffness of external fixation influences fracture healing. Gomez-Benito et al 
[63] developed a finite element model of a simple transverse mid-diaphyseal fracture 
of an ovine metatarsus fixed with external bilateral fixators of three different 
stiffnesses. They found that a lower stiffness (1150N/mm) of the external fixator 
delays fracture healing and causes a larger callus as compared with 1725 and 
2300N/mm external fixator stiffness. Carter et al. [64] examined the importance of 
cyclic motion and local stresses and strains on bone tissue formation. In this study 
they confirmed the basic mechanobiologic concepts that bone formation is promoted 
in the areas of low to moderate tensile strain, fibrous tissue is promoted in the areas 
of moderate to high tensile strains, and chondrogenesis is promoted in areas of 
hydrostatic compressive stress (pressure).  
 
Claes et al. [65] in a sheep model investigated the influence of the osteotomy gap 
size and intrafragmentary motion on fracture healing. They hypothesized that gap 
size and the amount of strain and hydrostatic pressure along the calcified surface in 
the fracture gap are the fundamental mechanical factors involved in bone healing. 
They proposed that intramembranous bone formation would form for strains smaller 
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than approximately 5% and small hydrostatic pressure of no more than 0.15MPa. On 
the contrary, strains less than 15% and hydrostatic pressure more than 0.15MPa 
would stimulate endochondral ossification. They also found that by increasing 
osteotomy gap size there was a significant decrease in the fracture healing process. 
Furthermore, they found that 2mm gap size led to greater intrafragmentary 
movement, bigger periosteal callus and increased amount of connective tissue in the 
fracture gap. Large, critical sized gaps of 6mm never healed during the period of 9 
weeks and they mainly produced fibrous connective tissue in the osteotomy gap 
regardless of the amount of intrafragmentary motion. 
 
Kenwright and Gardner [66] summarized studies that measured interfragmentary 
displacement in six degrees of freedom throughout healing in patients with tibial 
diaphyseal fractures treated by external fixation, and developed a finite element 
analysis model of healing tibial fractures. The model analysis predicted that tissue 
damage might occur in the later (hard callus) phase of healing, even while the 
fixation device is still in place, because of very high stresses and strains. This study 
also indicates that the mechanical environment should be better controlled to provide 
amplitudes of movement in the first weeks of healing and the rigidity of fixation 
should be increased to optimize fracture healing process until the fixator is removed. 
 
Another important factor that helps the healing process is mechanical stimulation. 
Therefore, it has been a goal of many investigators to find a relationship between 
mechanical stimulation and cellular responses under normal and defective bone 
healing. As early as 1955, Yasuda [67] discovered that the energy exerted on bones 
was transformed into callus formation. Despite his discovery, the ability to 
manipulate bone and other connective tissue by mechanical energy is still doubted by 
some, in spite of 52 years of basic science and clinical investigations [68-71]. Rubin 
et al. [72] discovered that repetitive loading under high frequencies or exercise 
regimen caused bone hypertrophy. Goodship et al. [73] also investigated strain rate 
and timing of mechanical stimulation in the fracture healing and hypothesized that an 
increased rate of deformation will enhance the osteogenic effects with short periods 
of cyclic micromovement, and that the maximal effect of such stimuli will occur in 
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the early stages of fracture healing. In this study they found that early application of 
rapid loading after osteotomy helps rather then hinders bone healing. 
There is clear evidence in the literature to confirm that bone cells and their 
precursors are sensitive to changes in their local mechanical environment and the 
importance of mechanical stimuli has been confirmed experimentally. However, the 
mechanisms by which mechanical signals control osteogenesis remain elusive.  
 
BMPs are essential for fracture healing, and genetically modified mice that lack 
BMP-2 lack all ability to heal fractures [74] Whether the magnitude and type of 
mechanical loading can enhance or decrease the amount of BMP expression has not 
been studied extensively. An in vitro study by Mitsui et al. examined the expression 
of BMPs, BMP receptors, BMP antagonists, transcription factors involved in 
osteogenesis and phosphorylation of Smad1 in cultured osteoblastic cells subjected 
to mechanical compressive force, and attempted to determine the optimal 
compressive force to induce osteogenesis. Interestingly, they found that compressive 
force induced BMP expression and there exist an optimal magnitude for expressing 
maximal amount of BMPs. However, a different study demonstrated that tension 
induced BMP-2 and BMP-4, but not BMP-6 and BMP-7, mRNA expression in an in 
vivo. The authors suggested that BMP-6 and BMP-7 genes, unlike BMP-2 and 
BMP-4, might not have stress response elements [75].   
 
In a different study by Kim et al. [76] investigators looked at osteoprogenitor cell 
responses to static mechanical stretch through interaction with biochemical 
components like BMP-2, or other osteogenic cytokines within the distracted tissue 
mimicking the gradual Distraction Osteogensis (DO) phase. They found that static 
stretching force combined with BMP-2 stimulation activates the osteoblastic 
differentiation of mesenchymal cells and stretch alone increases cell proliferation. 
Furthermore, they observed that the streching effect was more apparent at low 
concentrations of BMP-2 (50 and 100 ng/ml) than at high concentrations (200 
ng/ml), which are likely to be saturating. 
 
From the above-mentioned in vitro studies it is evident, that not only the type of 
mechanical loading could maximize BMPs expression, but also the magnitude of the 
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force. For this reason smaller doses of BMPs in combination with precise 
mechanical loading conditions could be used to heal fractures more efficiently.  
Collectively, the literature suggests that the healing of large segmental defects should 
be responsive to changes in the mechanical environment treated with rhBMP-2. 
However, there have been no in-vivo experimental studies to explore this possibility. 
 
 
 
 
1.6 HYPOTHESIS 
 
Based upon the information discussed in this chapter, we postulate that after the 
initial callus bridging enhanced by rhBMP-2 treatment, CSD healing should take the 
same or similar pathway as fracture healing. In this case for the optimal CSD healing 
I suggest that the external fixator should have low rigidity during the early stages of 
CSD healing so that the early callus formation occurs. The rigidity of fixator should 
be increased when the cartilaginous callus is formed and beginning of cartilage 
calcification is seen on the X-rays, which is around 14 days post surgery in the rat 
femur. This allows angiogenesis to take place, thus removing calcified cartilage and 
replacing it with woven bone. This suggests that a final period of higher rigidity will 
enhance bone formation and maturation in the most timely and efficient manner 
(Figure 1.10). It should be noted that my suggested mechanical regimen differs from 
standard clinical practice, where initial fixation is highly rigid. It also differs from 
those who promote dynamization of the fracture site. 
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Figure 1.10 Diagram showing a hypothesis of how fixator stiffness may be modulated to 
optimize bone healing (solid line - fixator stiffness, dashed l- compression) 
  
Thus my project paid particular attention to development of an external fixator that, 
in a controlled fashion, would impose the different stiffness environments necessary 
to test this hypothesis. The aims of this study were:  
 
1. The design and evaluation of a novel external fixator, which allows 
modulation of the mechanical environment within an experimental, 
critical-sized, femoral defect in the rat. 
2. In-Vitro mechanical testing of the fixator to determine its mechanical 
properties and the mechanical environment it produces within the 
defect. 
3. Investigation of the effect of the mechanical environment on the healing 
of an experimental, critical sized femoral defect in response to rhBMP-
2. 
4. The development of a modulated mechanical environment for bone 
healing in this rat segmental defect mode
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PROJECT AIMS 
 
1. The design and evaluation of a novel external fixator, which allows 
modulation of the mechanical environment within an experimental, critical-
sized, femoral defect in the rat. 
 
2. In-Vitro mechanical testing of the fixator to determine its mechanical 
properties and the mechanical environment it produces within the defect.  
 
3. Investigation of the effect of the mechanical environment on the healing of an 
experimental, critical sized femoral defect in response to rhBMP-2. 
 
4. The development of a modulated mechanical environment for bone healing in 
this rat segmental defect model. 
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CHAPTER TWO 
 
 
 
The design and evaluation of a novel external fixator, which allows modulation 
of the mechanical environment within an experimental, critical-sized, femoral 
defect in the rat 
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2.1 INTRODUCTION 
 
This chapter describes the design and construction of a novel external fixator for the 
rat femur that provides precise, standardised stiffnesses, which reliably create a 
known stress within the defect. The stiffness of external fixator could be modulated 
by pin offset, pin diameter, pin material, fixator bar length, fixator bar number, 
fixator bar material and fixator bar thickness. Fo this study, the fixator design to 
modulated stiffness was chosen by changing the stability bars. The reason for this 
was to allow presise modulation of fixator stiffness as bone healing progressed while 
it is still attached to the animal in-vivo. Although, there are two other ways to change 
stiffness in-vivo, one is by changing the offset of stability bar from bone surface, and 
the other by changing the number of bars. This type of change was avoided to 
prevent loosening of screws, which secure stability bar to pins. However, changing 
other design parameters mentioned above was not possible, and in some instances 
would have required an additional surgery for animals.  
 
The shape and materials for design of the fixator were spesificly chosen to mimic 
one used clinically. The weight and size were also carefully calculated by taking into 
account animal’s body weight. All other related question in regards to these choices 
will be further explained in the disccusion. 
 
Once designed, the components of the fixator were fabricated by the AO 
Development Institute (Davos, Switzerland). An extensive literature search failed to 
identify the prior design and construction of such a device for the critical sized 
segmental defect (CSD) in a rat model. Moreover, external fixators used previously 
for the fixation of such defects had not been quantitatively analysed to determine 
their mechanical parameters in-vitro and in-vivo in the same study, despite the 
knowledge that mechanical conditions influence bone healing process in fracture 
models. We have extensive, prior experience [54, 60] with a previous “first 
generation” fixator of high stiffness, originally designed by Einhorn and colleagues 
[62]. To enable comparison with our historical data, the novel “second generation” 
fixators were designed to give stiffnesses that were theoretically 100%, 70% and 
40% of the stiffness of the first generation device stability bar; ExFixHigh, 
ExFixMed and ExFixLow, respectively. 
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As well as enabling us to test our hypothesis (Chapter One) concerning the 
mechanical optimisation of the healing of large segmental defects, the novel fixator 
could provide the field with a standard instrument for use by other investigators. 
This would allow for a standardized experimental system to facilitate comparison of 
data between different groups of researchers. Such commonality is presently lacking, 
and is a source of confusion.   
 
Therefore, the aim for this study was to design and develop an external fixator with 
the possibility to adjust the stiffness in-vivo to allow optimization of bone healing 
process in the rat model.  
 
 
 
2.2 DESIGN OF THE FIXATORS 
 
2.2.1 First Generation Fixator Design and Surgical Implantation 
 
This fixator was designed for unilateral external fixation in the rat, and consists of 
rectangular, aluminium stability bar including holes for the application of Kirschner 
(K)-wires. The stability bar is 30mm in length, 7.5mm in width and 7.5mm in height. 
There are 4 holes through the stability bar; the distance between the outer and inner 
pins is 5mm and distance between the two inner pins is 10mm. The arrangement and 
design of the external fixator stability bar are shown in figure 2.1. Four 1.2 mm 
diameter K-wires (Figure 2.1 B) are fitted into corresponding holes in the external 
fixator stability bar (Figure 2.1 A) and fastened with locking screws. To avoid 
ambiguity, this fixator is referred to as ExFixOld throughout this thesis. 
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Figure 2.1 Components of the first generation fixator. The rectangular, aluminium stability 
bar (A) is fixed to the bone with K-wire (B). 
 
 
2.2.2 Surgical implantation of the First Generation External Fixator  
 
All animal procedures were approved by the ethics committee on animal care and 
use at Beth Israel Deaconess Medical Center, Boston, MA. Male Sprague-Dawley 
rats weighing 400-425 g were used for this study. Surgery was performed under 
sterile conditions and all animals were anesthetized with isoflurane. Before surgery 
all rats were given antibiotics cezazolin (dose 20mg/kg; 0.5mL) and the analgesic 
buprenorphine (dose 0.01-0.05 mg/kg) intramuscularly in the left leg. The entire 
right hind leg of the rat was shaved, cleaned with 70% ethanol and 10% iodine and 
draped with a sterile towel. An incision was made through the skin running 
craniolateral on the surface of the right femur (Figure 2.2A). The shaft of the femur 
was exposed by gentle dissection between the quadriceps and hamstring muscles. 
The right femur was exposed from the greater trochanter to the supracondylar region 
of the knee (Figure 2.2B). A template was placed on the craniolateral aspect of the 
femur to guide the drill and permit reproducible positioning of four drill holes with a 
diameter of 0.9mm. Irrigation during drilling irrigation prevented heat damage to the 
bone tissue. All four K-wires were driven into each drilled bone hole until their tips 
reached the outer surface of the cortex. All four K-wires were cannulated through the 
skin flap and the fixator stability bar was fastened at a preset distance from the bone 
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surface (Figure 2.2C). Using a dental burr of 4.5 mm diameter, 5mm critical-sized 
segmental defects were created and measured with callipers to make sure the exact 
size (Figure 2.2D&E). To minimize tissue damage in the bone, 0.9% saline solution 
during sawing was applied. The wound was closed in layers, to suture the muscle 
size 3-0 Vicryl, resorbable sterile suture (Ethicon) was used, and it was sutured 
underneath the external fixator. To suture the skin, 4-0 Nylon (MONOSOF), 
monofilament non-absorbable suture was used. (Figure 2.2F). On the first three 
postoperative days, the rats were given analgesic every 12 hours and antibiotic every 
24 hours. 
       
 
 
Figure 2.2A-F Surgical implantation of first generation fixator (ExFixOld) on the rat femur: 
A) rat is shaved and disinfected before the surgery; B) the incision is made in tissues until 
femur is exposed; C) four K-wires are inserted in the craniolateral aspect of the femur; D) 
the stability bar is secured on the K-wires with screws and the defect is made between two 
middle K-wires; E) 5mm defect; F) skin and muscle tissues sutured in layers. 
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2.3 NOVEL, SECOND GENERATION FIXATOR DESIGN AND SURGICAL 
IMPLANTAION 
 
2.3.1. Second Generation Fixator design   
 
The external fixator main frame consists of a polyethylethylketone (PEEK) body. 
Each external fixator has two connection elements and two main modules. Three 
different stiffness connection elements were developed to achieve different fixation 
stiffnesses equivalent to 40 (1.7mm), 70 (2.1mm) and 100% (2.5mm) of the stiffness 
of the first generation fixator (Figure 2.3), the absolute values of fixation stiffness 
will be described in detail in the next chapter. Each main module has two holes 
where the screws are inserted. The fixator stiffness can be changed while it is still 
attached to a living animal by changing connection elements with the wire 
applicator. Titanium (Ti) was used to make the mounting pins shown in the figure 
2.3. Four Ti screws are used to secure stability bar to the femur (Figure 2.3).  
 
 
 
Figure 2.3 Components of the novel external fixator. Three different stiffness connection 
elements, main module; titanium mounting pin and external fixator implanted on the femur 
with the defect.  
   
The second generation external fixator comes in four pieces and needs to be 
assembled prior to use (Figure 2.4A-F).  
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Figure 2.4A-F Assembly of the novel external fixator: A) 70% stiffness connection element; 
B) the connection element and one of the main modules; C) demonstrates how one of the 
main modules slides inside of the connection element; D) demonstrates how both of the 
main modules slides inside of the connection element; E) demonstrates both of the main 
modules and both connection elements in place; F) demonstrates fully assembled stability 
bar – main modules and connection elements secured with wires. 
 
  
                                        
                         
Figure 2.5 External fixator with a titanium screw inserted into the main module. 
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The distance between the outer screws is 4mm and the distance between the middle 
screws is 11mm. All holes are predrilled using 0.7mm drill bit. The screws are 
locked in corresponding holes of the main fixator frame, which is parallel to bone 
surface and set at the distance of 5mm from the bone (Figure 2.5). 
 
To create a 5mm segmental bone defect in the femur the saw guide was developed 
(Figure 2.6A.). The saw guide helps to create an accurate and precise 5mm defect 
every time, but also serves as a positioning guide for the installation of the external 
fixator. The main frame of the external fixator is clipped on to the saw guide and 
then the whole system is clipped on to the bone as shown in f igure 2.6B&C.  
 
       
 
                        
Figure 2.6 (A) Giggly saw guide; (B) External fixator clipped on the giggly saw guide   (C) 
Giggly saw guide with the external fixator clipped onto femur. 
 
To produce a 5mm transverse defect a micro Gigli saw is used. To minimize a slip-
stick effect, two elements of this saw are constructed from wires of different 
diameter. The thicker wire diameter 0.07mm serves as an axial core and the second 
wire diameter 0.04mm forms a cutting spiral with adjustable pitch around the core 
wire. The 5mm gap size was generated by using 0.22mm Gigli saw. Both of these 
pieces can be autoclaved at 134ºC (Figure 2.8E-I). 
 
Due to the miniature size of the external fixator a special set of instruments was 
designed and acquired for the implantation of this new fixator. A special screwdriver 
was developed to drive screws into the femur (Figure 2.7A&B). To create holes in 
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the bone a drill bit with a diameter of 0.75mm was used. When used together with 
the design of the self cutting tip of the screw radial preload results it was been shown 
that this prevents loosening due to bone surface resorption at the interface bone-
screw. The drill bit is operated by a miniature electrical pen drill producing 2500rpm 
at a power of 500mW (Figure 2.7C). 
    
 
 
Figure 2.7 Instruments designed for use with the novel fixator: (A) Screwdriver tip; (B) 
Screwdriver for the tip attachment; (C) Miniature electrical pen drill used to make holes for 
insertion of screws. 
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Figure 2.8A-I Implantation of second generation external fixator (ExFix): A) ExFix stability 
bar clipped on the Giggly saw guide, clipped on the femur shows first drilled hole with drill 
bit in place; B) demonstrates insertion of the first titanium screw in the outer distal part; C) 
demonstrates insertion of the second titanium screw in the outer proximal part; D) 
demonstrates insertion of two inner titanium screws (side view); E) demonstrates complete 
installation of the ExFix from the front; F) demonstrates giggly saw application through the 
saw guide; G) demonstrates giggly saw pasted through the saw guide grooves; H) 
demonstrates cut out 5mm defect with saw guide in place; I) demonstrates completion of the 
procedure without saw guide.   
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2.3.2 Surgical implantation of the Second Generation External Fixator  
 
Surgery was performed under sterile conditions and the rat was anesthetized with 
isoflurane (2% at 2 liters/min by air mask). Before surgery the rat was given 
antibiotic (cefazolin, 20mg/kg; 0.5ml of body weight) and the analgesic 
buprenorphine (dose 0.08 mg/kg; 0.5ml of body weight) intramuscularly in the left 
leg. The entire right hind leg of the rat was shaved, cleaned with 70% ethanol and 
10% iodine and draped with sterile fenestrated drape so only the right leg was 
exposed. An incision of approximately 3.5-4cm was made through the skin running 
craniolateral on the surface of the right femur from the greater trochanter to the 
supracondylar region of the knee (Figure 2.9A). The shaft of the femur was exposed 
by gentle dissection between the quadriceps and hamstring muscles (Figure 2.9B).  
 
The external fixator bar was used as a positioning guide, first clipped on to the wire 
saw guide and then placed on to the craniolateral aspect of the femur to guide the 
drill and permit reproducible positioning of four drill holes with a diameter of 
0.75mm (Figure 2.9C). A “Dremel” saw was used to drill all the holes for the screws 
one at the time, starting either with the distal or proximal side. It is very important 
that the first screw is perfectly perpendicular to the craniolateral aspect of the femur 
and the external fixator bar before drilling. Once the first hole was made the screw 
was driven into the femur on the distal/proximal side, first through the external 
fixator bar and then into the bone making sure that it entered perpendicularly into the 
femur (Figure 2.9D). 
 
Chapter Two
 
 
 59 
                
 
Figure 2.9A-I Surgical implantation of the second generation external fixator (ExFix) on the 
rat femur: A) shows incision made in the skin to expose muscle; B) shows incision made 
through the muscle to expose femur; C) ExFix stability bar clipped on the saw guide and 
placed on the femur for the implantation: D) first titanium screw screwed into bone through 
the distal hole of the stability bar; E) second titanium screw screwed into bone through the 
proximal hole of the stability bar; F) titanium screws screwed into bone through two inner 
holes on the stability bar; G) demonstrates created 5mm segmental defect; H) demonstrates 
completion of the surgical procedure with ExFix in place without the saw guide; I) 
demonstrates sutured skin with exposed ExFix stability bar. 
 
After the first screw was in place, the most distant hole from the first screw was then 
drilled, and the second screw was driven into the hole (Figure 2.9E). The 
implantation order of the two middle screws is not important as long as they are 
perfectly perpendicular to the craniolateral femoral surface (Figure 2.9F). After the 
fixator was in place the saw guide was used to make the segmental defect. For this, a 
0.22mm wire (Gigly) saw was passed through the 2 grooves underneath the femur to 
create a 5mm segmental defect by reciprocal motion back and forth (Figure 2.9G). 
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After the defect was created, the saw guide was removed and any treatment (e.g. 
rhBMP-2) added to the defect area. The wound was closed in layers, the muscle first 
and then the skin (Figure 2.9H). On the first three postoperative days, the rat was 
given analgesic every 12 hours and antibiotic every 24 hours. 
 
       
 
 
 
Figure 2.10. Novel fixator in place across a rat, femoral 5mm defect. The stability bar of 
first generation, ExFixOld, is shown bellow for comparison. 
 
 
2.4 DISCUSSION 
  
As described here, a novel external fixator was designed and a prototype 
manufactured. The primary innovation of this fixator was the ability to exchange the 
stability bar connective modules to select different, standardized stiffnesses. Because 
the stability bar’s connective elements can be exchanged while the device is attached 
to the animal, the stiffness can be adjusted at different stages during the healing 
process. This is important for the studies described in the Chapter 5. Although three 
different stiffnesses were generated for the present work, additional stiffnesses could 
be achieved by fabricating additional connective elements of different thicknesses 
for the stability bar. 
 
The screws and main frame were made from Ti and PEEK, respectively, because 
these materials are already used for orthopaedic implants in humans and their 
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biocompatibility is well established. These materials also allow in-vivo imaging in 
the early stages of fracture repair with a minimal distortion, and reduce the incidence 
of infections.  
 
As an additional design feature, the fixator was made so that it has preset offset of 
6mm from the bone surface to the stability bar no matter which stiffness connection 
elements are used. This has an advantage over ExFixOld where offset was 
predetermined by measuring the distance on the K-wire and making a mark with a 
marker pen, and then sliding the stability bar on the marks before securing with the 
screws. This method was not very reproducible and this could be one of the reasons 
why this animal model had high variability. 
 
Another big advantage over alternative designs described in the literature [62, 77] 
including the one we have used in the past, is that the new external fixator was 
designed to have a minimal mass to avoid uncontrolled loading due to inertia. The 
new fixators were made taking into account rat body weight and the size of femur 
and this relationship was scaled accordingly as is done with human fixation devices.  
 
To keep the surgical trauma low, conventional and rotating saws were not considered 
as tools for creating 5mm critical size defects. Such saws either cut into adjacent 
tissue or strip off the periosteum when the tissues are retracted. In the past we have 
used a 4.5mm dental burr saw to create 5mm defects and found that it was 
impossible to create exact and reproducibly sized defects with parallel ends. To 
avoid all these problems we took an advantage of the Gigli saw. A conventional 
Gigli saw has substantially different static and kinetic friction and two intertwined 
diamond cords create very minimal damage to the bone while cutting. The saw guide 
was developed for creating precise defects with the parallel ends every time. 
 
The in-vivo pilot experiment was performed with the new external fixator prototype 
to make sure that it meets all proposed demands before it is manufactured in larger 
quantities. The results of the first evaluation of the in-vivo performance at the time of 
surgery showed that the distance between the bone and the stability bar, needed to be 
increased by 3mm to avoid impinging the skin immediately after surgery due to 
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tissue swelling. This was achieved by changing the screw length, a modification that 
resulted in minimal change in the overall stiffness of the construct. 
 
In conclusion, in this study I was able to develop a standardized method for bone 
fixation in this CSD rat model, which produced a controlled mechanical 
environment. Furthermore, the first in-vivo pilot data demonstrate that it is a highly 
reliable and reproducible method to study bone repair of long bones in the rat model.  
 
Having successfully designed this device and demonstrated the merits of a prototype, 
the fixator was subject to further, detailed, quantitative analysis to determine its 
precise mechanical properties and the mechanical environment it generates within a 
segmental defect in-vitro and in-vivo. These studies are described in the following 
two chapters.
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CHAPTER THREE 
 
 
Determination of the in vitro mechanical properties of first and second generation 
external fixators 
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3.1 INTRODUCTION 
 
 
A number of studies have improved our understanding of the biologic mechanisms 
involved in bone tissue repair [62, 78-82]. The effects of mechanical conditions on 
bone repair such as axial, shear and IFM have been studied extensively [40, 83-91]. 
On the contrary, the in-vivo mechanical environment generated by fixation is rarely 
investigated in detail. 
 
Data on compliance, stiffness, torsional rigidity and IFMs are rarely tested in-vitro 
and described in detail in existing models of fracture fixation to determine fixation 
mechanical properties prior to in-vivo experiments. Fixation device mechanical 
properties are even more important when studying bony healing of CSDs to establish 
fixation that provides not only a constant gap size throughout the experiment period 
of full weight bearing, but also a perfect mechanical environment for the healing 
bone.  
 
The choice of fixation device is very important and should be carefully selected 
depending on the study design, and other factors such as gap size and the type of 
fracture. Different types of intramedullary nails, internal plates and external fixators 
have been used in the experimental studies as well as in the clinical practise to 
stabilize the fragments of broken bones. Several studies examined the influence of 
fixation stiffness in the rat femoral fracture model by comparing different types of 
nails [92-94] or comparing intramedullary nails made from different materials [95-
98]. Yet, only half of them reported in-vitro evaluation for their nail devices such as 
axial and torsional stiffness [93, 94, 96, 97] prior to in-vivo studies. External fixation 
devices used for distraction osteogenesis [75, 82, 99-105], fracture fixation [77, 106-
111] and large defect models [54, 112-115] allow controlled and reproducible 
mechanical environment in the rat femoral fracture model.  
 
The mechanical characteristic of a specific external fixator are major factors in 
determining the biomechanical environment at a fracture, osteotomy and most 
importantly at the segmental defect site, hence, it has an effect on the healing 
process. Although the optimal biomechanical environment for healing of a fracture 
or an osteotomy is unknown, a specific range of interfragmentary motion (IFMs) 
Chapter Three
 
 
 65 
exists which promotes healing. It is therefore desirable that the mechanics of an 
external fixator can be manipulated to enable control of the range of IFM. The 
characteristics of an external fixator are defined and can be modulated by a large 
number of variables, which include: pin offset (distance between the pins), pin 
diameter, pin material, the amount of pins used, fixator bar length, fixator bar 
number, fixator bar material, fixator bar thickness and distance from the bone 
surface to the fixator bar, or so the called offset. Therefore, to gain control over the 
degree of IFM and gian a clear understanding of the effect of each variable and how 
it interacts with the others is to determine the overall characteristics of the device 
required. In the past several years only a few studies investigated the effect of 
individual components and whole frame configurations and how this effects system 
stiffness used in the experimental small animal models [77, 106, 107, 116]. 
 
An in-vitro study by Mark et al. [77] found that the distance between the bone 
surface and the fixator (offset) was linearly related to the stiffness in axial loading of 
rat bone and brass rod constructs. Furthermore, a 0.2mm decrease in pin diameter 
changed the axial stiffness of rat bone by about 50%. They also found that if the 
bone fragments touched, the axial stiffness increased almost 10 times as compared to 
a gap size of 2mm. 
 
Harrison et al. [106] reported no difference in axial stiffness when different materials 
such as aluminium and titanium were used for the stability bar in-vitro, and 
increasing the osteotomy gap from 1 to 3mm decreased the mean axial stiffness by 
only by 6% for the three fixator frames tested. In the in-vivo study they showed that 
while using the same fixation conditions and changing the gap size from 0.5 to 3mm 
the pattern and progression of repair process were very different. In the group with 
0.5mm gap bone, union was attained by around 5 weeks and the torsional strength of 
intact femur was reached by week 9 post-surgery. In contrast, a consistent pattern of 
atrophic fibrous pseudoarthrosis was seen in the group with the 3mm gap due to 
larger IFMs. 
 
Study by Willie et al. [116] found that the contribution to the total stiffness of the 
fixation construct was dominated by the flexibility of the pins in relation to their 
offset, diameter and material properties. For example, titanium pins resulted in 
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significantly lower axial stiffness compared to stainless steel pins of the same 
design. 
 
It is evident that external fixators are commonly used in fracture and segmental 
defect healing experimental models because they have an advantage over other 
fixation devices. The main advantage of the external fixators are that they allow the 
change of mechanical environment at the defect site in-vivo, which can be achieved 
by changing or adjusting the stability bar of the device during the course of the 
experiment as the bone healing progresses. Moreover, it permits the application of 
specific local mechanical stimulation to enhance the repair of bone, and also 
provides the potential to measure stiffness of callus tissue in-vivo. Although the 
devices have also a few disadvantages that include: irritation of soft tissue, infections 
and breakage of pins. 
 
The studies mentioned above mechanically characterized the in-vitro fixation 
stiffness and its effect on different modes of loading by changing gap size, material 
of the stability bar, pin diameter and offset in different models. The difficulty in 
assessing the importance of these studies arises from the uncertainty as to whether 
the experimental conditions were realistic. This raises the question of whether the 
observed behaviour in these studies is representative of real fractures and provide an 
increasing constraint to movement throughout the healing process. Moreover, in the 
natural environment of fracture healing, different amounts of loads such as axial, 
bending and shear arise not only from fixation device stability, but also from weight 
bearing, muscle forces, tendon and ligament activity. While this type of loading is 
very complex and would be hard to model experimentally, a more realistic approach 
is needed so that the influence of the mechanical environment on healing fractures 
are better understood and interpreted. Most of the in-vitro models with fixation 
devices found in the literature are tested with different gap sizes. Although this 
explains the mechanical conditions to some extent, in reality fracture gaps have 
various types of tissue within them, depending on the healing phase. Therefore, to 
determine “true” local mechanical environment for the healing fracture is not really 
possible using existing methods. In particular, the contribution of the repair tissue 
with the lesion to overall stability has been ignored. 
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In the literature I found only one in-vitro study [117] that looked not only at the local 
mechanical environment provided by five different types of clinical external fixators, 
both dynamized and non-dynamized, but also at the effect of the resistance to axial 
IFM created by four different stiffness materials simulating the main stages of the 
healing process. Using fixators implanted on glass fibre tubing in axial compression 
to simulate weight bearing, Gardner et al. [117] found that if there is no material 
present in the fracture gap, which simulates the conditions immediately post-surgery, 
the fixator frame provided complete stability at the fracture site, and there was no 
contribution from the gap (fibre glass tube) to support the fracture site. On the 
contrary, when they interposed material with the lowest stiffness, which represents 
early stages of fracture healing, they found that the mechanical properties of the 
fixator were as important as those of the fracture material in influencing axial IFM at 
around two to four weeks post fixation. Furthermore, the five clinical external 
fixators tested contributed differently depending on their stiffness. In contrast, using 
three stiffer intra-fracture materials, simulating all but the initial stage of fracture 
healing, axial movement was influenced only by the stiffness of these materials and 
only slightly influenced by the contribution of the fixation devices. Nevertheless, 
angular, transverse and torsional shear movements were enhanced, depending on the 
type of the fixator. These motions were also enhanced by unlocking the fixator to 
initiate fixator looseness.  
 
The studies of Gardner et al. [117] demonstrate the importance of including 
contributions by the intra-defect tissue when analyzing the overall mechanical 
environment created by an individual fixation device, but, to my knowledge, no 
study to date has extensively investigated this interaction. Thus, in the next stage of 
my studies, I undertook a series of in-vitro mechanical studies to determine the 
stiffness created by each of the fixators when a standard material of known 
mechanical properties was inserted into the defect. Each of the inserts represented a 
different tissue that would be present in the defect during healing process. The 
hypothesis for this part of the experiment is that the mechanical boundary conditions 
and the external fixator stability are the most important at the initial phase of CSD 
healing and will determine the success of it. The aim for this part of the study was to 
determine mechanical properties of the external fixators described in the previous 
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chapter and to estimate how they influence the mechanical properties of a rat 
segmental, femoral defect during the main stages of healing. For the first objective 
three point bending measurements were used to determine the mechanical properties 
of the stability bars; and for the second objective fixators were then attached to intact 
rat femur and to femur with a 5mm segmental defect. To simulate three of the main 
stages of healing, rubber, low-density polyethylene or wood was inserted into the 
defects. In each case, axial compression testing, simulating weight bearing, was used 
to determine mechanical properties of the construct. 
 
Data from this study provide a better understanding of mechanical conditions needed 
at the different stages of osseous repair for rapid and most efficient healing under the 
weight bearing.  
 
 
 
3.2 MATERIALS AND METHODS 
 
3.2.1 MATERIALS: External Fixators 
 
In this experiment all external fixators ExFixOld, and newly designed external 
fixators with ExFixLow, Medium and High (see earlier comment about 
nomenclature) were tested empirically by in-vitro mechanical testing to determine 
detailed mechanical characteristics. The dimensions and materials of all external 
fixators are described in chapter two. 
 
3.2.2 METHODS 
 
 3.2.2.1 3-Point-Bending of Stability Bars  
 
Non-destructive 3-point-bending mechanical tests with 6 samples per group were 
used to determine the mechanical properties of the stability bars for all external 
fixators. Because of its size difference the ExFixOld was tested with different 
mechanical parameters.  
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For the ExFixOld fixator, load was applied midway between two supports that were 
25.94mm apart; the diameter of the supports was 4mm (Figure 3.1A). Load-
displacement curves were recorded at a crosshead speed of 1mm/min to a 2% strain 
rate or a maximum force of 250N using Mechanical Testing System Synergie 200. 
The force/displacement data was acquired at 100Hz. The bending stiffness was 
calculated from the linear region of the load-deflection curve.  
 
      
Figure 3.1 Images illustrating 3-point-bending rig for testing of the external fixator stability 
bars: (A) ExFixOLD aluminium stability bar; (B) ExFixLow PEEK stability bar. 
 
Because the ExFixLow, Medium and High fixators were much smaller in size than 
the ExFixOld the load was applied midway between two supports that were 
14.09mm apart; the diameter of supports was 1.95mm (Figure 3.1B). Load-
displacement curves were recorded at a crosshead speed of 1mm/min to a 2% strain 
rate or a maximum force of 250N using Mechanical Testing System Synergie 200. 
Samples were preloaded ∼8N before each test. The force/displacement curves were 
acquired at 100Hz rate. The bending stiffness was calculated from the linear region 
of the load-deflection curve (Figure 3.2).  Three point bending test was chosen only 
to test if in fact there was 30% differences between each stiffness fixators. The main 
advantage of a three point bending test is the ease of the specimen preparation and 
testing. While this method has also some disadvantages like the results of testing 
method are sensitive to specimen and loading geometry and strain rate. Since the 
shape and heterogeneity of fixator materials were uniform this test was appropriate 
to determine difference in stiffness between them.  
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Figure 3.2 Data from one representative sample shows an example of load-displacement 
curves from 3-point-bending test of stability bars for different stiffness external fixators: 
ExFixOld, ExFixLow, Medium and High with 8N preload.   
 
 
 
3.2.2.2 Axial Compression Validation Test of Materials 
 
In this test four materials were chosen to simulate the different types of tissue at the 
various stages of the bone healing process. Their selection was based upon the 
mechanical data of Morgan et al. [118] (Table 3.1). A rubber insert was chosen to 
simulate the early stage of healing, at the time when the haematoma within the defect 
is being replaced by cartilage. According to the literature, at this stage of healing the 
tissue elastic modulus is about 0.01-0.1GPa [118], which is in the same range as 
rubber. For the subsequent stage, at which calcified cartilage is being replaced by 
woven bone, low-density polyethylene (LDPE) was chosen to simulate tissue 
stiffness, which has been reported to be in the range of 0.2-0.9 GPa [118]. For the 
final stage of bone healing, during which woven bone is maturing into lamellar bone, 
two different woods were evaluated as to their proximity to physiological stiffness. 
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Cortical bone elastic modulus at this stage has been reported in the range of 10GPa; 
therefore maple and oak were the appropriate choice [118]. 
 
Tissue Type 
 Granulation Tissue 
n=10 
Chondroid tissue   
n=18 
Woven bone 
n=41 
Mean (MPa) 0.99 3.10 201.16 
Median (MPa) 0.99 2.89 132.00 
SD (MPa) 0.20 1.30 200.85 
Max (MPa) 1.27 4.42 1010.00 
Min (MPa) 0.61 1.39 26.92 
  
 
Table 3.1 Indentation moduli for three tissue types in an unstabilized facture (SD - standard 
deviation) from Leong, P.L. and Morgan, E.F. “Measurement of fracture callus material 
properties via nanoindentation”, Acta Biomater. 2008 September; 4(5): 1569–1575 [119]. 
 
Axial compression testing was performed to confirm that their stiffnesses, as 
measured under our experimental circumstances, corresponded to those reported in 
the literature. Rubber and LDPE were purchased in a sheet of 12×12 inches with 
6.35mm in thickness. Rubber was cut into 25×25mm squares with length of 6.35mm 
and LDPE was cut into 5x5mm with length of 15mm for testing. Maple and oak 
were purchased as rods 36 inches long and 9.54 mm in diameter and cut into 5.5 mm 
thickness samples for the testing. Six samples per group were used to determine the 
Young’s moduli of these materials in axial compression testing with an Instron 8550 
mechanical testing system. Load-displacement curves were recorded at a crosshead 
speed of 0.5mm/min to a 5% strain rate using a 2224N load cell. The 
force/displacement curves were acquired at 100Hz (Figure 3.3). 
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Figure 3.3 Data from one representative sample shows an example of load-displacement 
curves of materials: rubber, LDPE, maple and oak tested in an axial compression mode. 
 
 
 
3.2.2.3 Axial Compression Testing  
 
After stability bar and material testing was completed, axial compression testing was 
used to determine the mechanical environment created when the 4 different stiffness 
external fixators were fixed onto rat femora with and without the defect. For this 
experiment the external fixators ExFixOld, ExFixLow, Med, and High (see earlier 
comment about nomenclature) were fixed in position on the right femur of a total of 
eight Sprague-Dawley rats, with 2 rats per group. After the external fixators were in 
place the 5mm segmental defect was created in one of the femurs in each group and 
then the femurs were excised from the body. The procedure was performed in this 
manner to avoid drying out and cracking of the bones during the procedure. Also, 6 
intact contralateral femurs were used as controls. Both ends of each specimen were 
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embedded in polymethylmethacrylate (PMMA) to provide a reproducible, flat 
interface with the testing fixture. The four different test materials were put into 
defects to simulate different stages of fracture healing. The thickness of all materials 
was cut to 5.5mm to fit the defect tightly; the diameter for the wood was 9.54mm, 
rubber and LDPE was cut into 6 by 6mm squares. Since the specimens where tested 
in compression the area of the material inserts in the defect had no effect on 
mechanical properties. Six samples from each material were placed in the segmental 
defect for each of the different fixators to determine the mechanical environment 
(Figure 3.4). After each test constracts from all groups were taking out from 
mechanical fixture, then one of the material samples were inserted into the defect 
and repositioned in the mechanical testing machine. 
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Figure 3.4 Representative examples of femur constructs tested in axial compression with 
various stiffness fixators and different materials in the defect gap: (A) Intact femur; (B) 
ExFixOld no defect; (C) ExFixHigh no defect; (D) ExFixOld rubber insert; (E) ExFixOld 
LDPE insert; (F) ExFixOld maple insert; (G) ExFixHigh rubber insert; (H) ExFixHigh 
LDPE insert; (I) ExFixHigh maple insert.   
 
 
Load-displacement curves were recorded at a crosshead speed of 0.5mm/min to a 
1.5% strain using an Instron 8550 mechanical testing system. The 
force/displacement curves were acquired at 100Hz rate. The stiffness of the construct 
was automatically calculated from the linear region of the load-deflection curve 
(Figure 3.5).  
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Figure 3.5 Data from one representative sample shows an example of load-displacement 
curves from axial compression test of femur constructs with various stiffness fixators: 
ExFixOld, ExFixLow, Medium and High, and different materials in the defect gap: (A) No 
Defect; (B) LDPE; (C) Maple.   
 
 
3.2.2.4 Statistical Analysis 
 
For the stability bar and the material mechanical testing, comparisons of continuous 
variables between the groups were performed using analysis of variance (One Way-
ANOVA). If the difference between the ExFixOld and other groups was significant, 
a posthoc test (Tukey) was performed. A post-hoc test was performed because of the 
limitation of the results from a One-Way ANOVA, this statistical test does not show 
how the means differ, and only shows that the means are not equal to each other. 
Therefore, to see how the means differ from each other post-hoc tests were used. A 
post-hoc test is conducted always after determining if there is a difference among the 
means being compared. To compare tested materials (rubber, LDPE, maple and oak) 
an unpaired t-test was performed, with differences considered significant at p<0.05. 
For the axial compression test statistical analyses were performed using either 
analysis of variance (Two Way-ANOVA) or a two-tailed t-test to determine if there 
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was a significant correlation between the stiffnesses of the different fixators and the 
materials used.  
 
A power analysis after the study was calculated to determine if we had sufficient 
numbers of samples per group to detect a significant difference. The power level for 
all the data was found to be from 0.9 to 1. Thus the number of samples per group 
used in these studies are enough to determine a 5% difference between the test 
groups. All tests were two-tailed, with differences considered significant at p<0.05. 
Data are presented as mean±SE, unless otherwise noted. 
 
 
3.3 RESULTS 
 
3.3.1 Three Point Bending of Stability Bars 
 
Three point bending tests performed on the x axis or anterior laterral of stability bar 
revealed that ExFixOld, with the large aluminium bar, had six times higher stiffness 
than the ExFixHigh, the stiffest of newly designed fixators. The stiffness for the 
ExFixOld was 1487 N/mm and for the ExFixHigh was 254 N/mm and this was 
statistically significant, p<0.0001. Statistically significant differences were seen 
between the stiffnesses of all fixators tested, p<0.0001(Figure 3.6).   
 
Three newly designed fixators were tested to determine actual stiffness and also to 
confirm that they indeed have 30% difference from each other, as intended. 
Mechanical testing showed that the stiffness for ExFixLow, Med and High was 114, 
185 and 254 N/mm respectively and they were significantly different from each 
other, p<0.001. Calculated percent differences showed that the ExFixHigh was 27% 
stiffer than the ExFixMed and this difference was significantly different, p<0.0011. 
The difference between the ExFixMed and ExFixLow was 38% and this difference 
was also statistically significant, p<0.0008 (Figure 3.6). 
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Figure 3.6 Stability bar stiffness in 3-point-bending for four different stability bars: 
ExFixOld, ExFixLow, Med and High. Values given are means ± SEM; Dollar signs indicate 
statistical significant difference from ExFixOld, and hash signs indicate significant 
difference from ExFixHigh (p < 0.05, n=6 per group).  
 
 
3.3.2 Axial Compression Validation Testing 
 
Axial compression testing was performed to confirm Young’s modulus for rubber, 
LDPE, maple and oak as cited in the literature. Young’s modulus is a measure of 
stiffness of an isotropic elastic material. It is defined as a ratio of the uniaxial stress 
over the uniaxial strain in the range of stress. These tests showed that Young’s 
modulus for all four materials falls within the range reported in the literature (Table 
3.2). 
 
Materials 
Young’s modulus(GPa) 
(Wikipedia) 
Young’s modulus(GPa) 
Axial Compression Test Data 
Rubber 0.01-0.1  0.074 
LDPE 0.2 0.197 
Maple 9-10 9.8 
Oak 11 10.6 
 
Table 3.2 Young’s modulus values for materials: rubber, LDPE, maple and oak reported in 
the literature and compared to the axial compression test performed in the laboratory. 
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Axial compression test revealed that there was no significant difference between 
maple and oak. Therefore, for further in-vitro testing maple was chosen due to its 
smaller inter - sample variability. 
 
There was a statistically significant difference when rubber was compared to LDPE 
and both woods, p< 0.0001. The significant difference was also seen when LDPE 
was compared to all the materials tested, p<0.0001 (Figure 3.7). 
 
 
                  
 
Figure 3.7 Young’s Moduli calculated from axial compression of four different materials: 
rubber, low-density polyethylene (LDPE), maple and oak. Values given are means ± SEM; 
Dollar signs indicate statistical significant difference from LDPE, hash signs indicate 
significant difference from rubber and asterisks signs indicate significant difference from 
oak (p < 0.05, n=6 per group).  
 
 
 
 3.3.3 Axial Compression Testing 
 
Axial compression mechanical testing was used to determine the local mechanical 
properties within the critical size defects imposed by the four different stiffness 
fixators. First, the influence of the fixators on the stiffness of intact rat femur was 
determined, then the three different materials validated in the previous section were 
each inserted in turn into defects in the rat femur. 
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Using intact femur, axial compression testing revealed that the highest stiffness was 
achieved in the group with ExFixOld (Figure 3.8A). Indeed, placement of the fixator 
increased the stiffness of the intact femur by approximately 48%. The other external 
fixators, in contrast, had only minor effects on the stiffness of the intact femur: for 
example, with the ExFixLow the construct stiffness increased only by 5% as 
compared to the intact femur, for ExFixMed and High the stiffness increased by 15% 
and 20% respectively (Figure 3.8A). When ExFixOld construct was compared to the 
ExFixLow, Med, High external fixators, this difference was 45, 40 and 28% 
respectively.  
Having tested intact bone, 5mm defects were created in the femur and tested without 
any inserts to see stability of constructs (Figure 3.8B, Table 5.3). The constructs with 
empty defects with four different stiffness fixators were tested to determine construct 
stability without any material inserts. The results showed that the construct that had 
ExFixOld fixator had lowest stiffness when compared to ExFixLow, Medium and 
High and this was significantly different. There was also significant difference 
between Low, Medium and High external fixator. The results using a rubber insert to 
simulate early stages of healing showed that the construct with the ExFixOld had at 
least 3 fold lower stiffness as compared to all three of the new ExFixs and this was 
significantly different from all other external fixators, p<0.0001. Significant 
differences were also seen when ExFixHigh was compared to ExFixLow and Med, 
p<0.001. Furthermore, the ExFixLow construct was less stiff than ExFixMed and 
this was also significantly different, p<0.0001 (Figure 3.8C, Table 5.3). 
 
In the third test low density polyethylene (LDPE) was used to simulate a later stage 
of fracture healing at which cartilage is being replaced by woven bone (Figure 3.10). 
The results revealed that significant differences were seen when the ExFixHigh 
construct was compared to the other three external fixators, (p<0.001). However, the 
difference was small compared to that seen at other simulated stages of healing; 
indeed the ExFixOld, ExFixLow and Med showed no difference when they were 
compared to each other (Figure 3.9D, Table 5.3). 
 
Finally, to simulate the third stage of fracture healing, when woven bone is maturing 
into lamellar bone, maple was inserted into the defect for each construct (Figure 
3.9E, Table 5.3 & 3.10). The highest construct stiffness was observed with the 
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external fixator ExFixOld and this was significantly different from the other three 
external fixators, (p<0.0001). Interestingly, there was no difference between the 
ExFixLow, Med and High constructs when maple was used in the defect (Figure 
3.9E, Table 5.3). Overall, Two Way Anova statistical test revealed that there is 
significant interaction between the materials and external fixators used (p<0.0001). 
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Figure 3.8 Stiffnessses created by the different fixators applied to rat femur. 
ExFixOld, and ExFixLow, Med, High were placed upon isolated rat femora. (A) Intact 
femora and (B) femora with 5mm empty defect without an insert were tested in an axial 
compression mode (C) femora with 5mm empty defects containing rubber were tested in an 
axial compression mode. Values given are means ± SEM; Asterisks indicate statistical 
significance from ExFixOld, dollar signs indicate statistical significant difference from 
ExFixHigh, and hash signs indicate significant difference from ExFixLow (p < 0.05, n=6 per 
group).  
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Figure 3.9 Stiffnessses created by the different fixators applied to rat femur. 
ExFixOld, and ExFixLow, Med, High were placed upon isolated rat femora. (D) Femora 
with 5mm defects containing low density polyethylene (LDPE) and (E) maple were tested in 
an axial compression mode. Values given are means ± SEM; Asterisks indicate statistical 
significance from ExFixOld, dollar signs indicate statistical significant difference from 
ExFixHigh, and hash signs indicate significant difference from ExFixLow (p < 0.05, n= 6 
per group).  
 
 
 
 
 
 
Figure 3.10 Stiffnesses created by different fixators: ExFixOld, ExFixLow, Medium and 
High, with various inserts: rubber, LDPE, wood and intact bone in the CSD simulating 
stages of bone healing, tested in axial compression, n=6 per group. 
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3.4 DISCUSSION 
 
These data confirm that the design of an external fixator has a major influence on the 
mechanical environment experienced by a healing segmental defect, as reflected in 
the stiffness of the system. Although the stiffness of the stability bar is an important 
determinant of this property, it is also influenced by the nature, diameter, position 
and quantity of the pins, preset offset from the bone surface to the stability bar and, 
to a surprising degree, by the mechanical properties of the material within the 
segmental defect.  
Knowledge of the mechanical properties of the fixation device is very important 
because its stiffness determines mechanical environment of the healing bone and the 
healing pathway that it is going to undertake. Given this state of affairs, it is 
remarkable that there is little in the literature on the in vitro mechanical 
characterization of devices used for in-vivo animal studies. 
 
Although the stability bar of the ExFixOld was approximately 3-fold higher than 
those of the new fixators, it provided only 30-40% of the stiffness of the new fixators 
when placed across a 5mm defect with a rubber insert to simulate an early stage of 
healing. This dramatic decline in stability is presumably due to the greater distance 
of the ExFixOld stability bar from the bone and the diameter of the pins. For our old 
generation fixator we used 1.2mm diameter stainless steel K-wires with the offset of 
25mm from tip of the pin, with our new generation external fixators we used 1mm 
diameter titanium pins with the offset of 11mm. The importance of pin diameter and 
offset have previously been noted by Willie et al. [116], who found that the 
contribution to the total stiffness of the fixation device was dominated by the 
flexibility of pins in the relation to the offset, diameter and material properties. In 
agreement with this, a study by Mark et al. [77] also found that axial and torsional 
stiffness was significantly increased depending on the diameter and material of pins 
used. Titanium pins led to about 40% lower axial stiffness and 30% lower torsional 
stiffness than the stainless steel pins. Furthermore, this finding is also in the 
agreement with a study by Gardner et al. [117] where they observed that during 
initial stages of healing there is very little tissue solidity at the fracture site and it is 
then that the degree of support from the interposing fragments is very critical and 
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mainly depends on the fixation stability. This period might be prolonged or delayed 
in the case of poorly supported fractures. In this regard it is noteworthy to mention 
that all of the fixators, provided sufficient strength to a femur with a 5mm defect to 
allow testing to be performed, however the ExFixOld has the least amount of 
stability as compared to the other stiffness fixators. It is possible that under in-vivo 
conditions, the surrounding soft tissue provides sufficient stability to initiate a 
healing response. 
 
When the simulated intra-lesional healing tissue progressed from haematoma-
cartilage (rubber insert) to calcified cartilage-bone (low density polyethylene insert), 
the ExFixOld provided greater stability, approximately equal to that of the new more 
rigid fixators. Similar phenomenon was also observed in the study by Gardner et al. 
[117] where they found that the amount of axial movement was largely controlled by 
the material in the fracture gap rather than by the fixator stiffness. Which in part 
explains the findings in the current study, it appears that in the ExFixOld group 
stiffer material in the gap was able to take over and support most of the load and the 
low stiffness fixator device had minimum effect.  
 
At the stage of immature-mature bone (wood insert), the ExFixOld provided much 
greater stiffness than any of the new fixators, equal to about 80% of the native 
femur. When placed on an intact femur, the ExFixOld approximately doubled the 
stiffness of the system, unlike the new fixators that had relatively little effect. This 
observation in the ExFixOld construct group could be related to the other loading 
conditions such as torsional or transverse shear. It seems that when the defect 
material is at the maximum stiffness and the fixation device is loose, the system is 
subjected to enhanced shear loads [117], which have been shown to be detrimental to 
bone healing. On the other hand, because the new generation external fixators are 
more rigid shear loads are very minimal and hardly contributes to the overall 
stiffness of the system; similar results were also observed by Gardner et al. [117].  
 
The results from this study thus confirm that the fixators used in this project provide 
an experimental range of mechanical environments that can be used to investigate 
the role of this environment on healing. This is important because through 
observational and to the lesser extent empirical study, several theories have been 
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developed on the role of the certain mechanical stimuli governing differentiation of 
pluripotent mesenchymal tissue into fibrous tissue, fibrocartilage, cartilage and bone 
[38, 41, 65, 120, 121]. In nearly all fracture treatments require the use of the artificial 
support to stabilize bone fragments; therefore the major determining factor of 
mechanical environment at the fracture site and the subsequent pattern of healing is 
the fixation device stiffness. Testing the effects of mechanical environment on 
fracture healing requires measuring the distribution of mechanical stimulus in the 
fracture callus. This is a very complicated task, because at the tissue level 
mechanical stimuli are determined not only by the types of applied loads such as 
axial, transverse and bending to the healing bone, but also by the geometry, fracture 
gap and mechanical properties of the callus tissues. This is why many investigators 
tackle this by using computational models where they can control and use different 
mechanical parameters to simulate different stages of fracture repair. Mine is one of 
the few studies to make empirical measurements of these parameters. 
 
In conclusion, it appears from this study that mechanical conditions experienced at 
the site of a segmental defect are highly sensitive to the material properties and 
design of fixators, and these are further modulated by the material properties of the 
tissues present in the gap. This suggests the potential for interesting and important 
mechanical and biological interactions between the fixator stiffness and the tissue 
type being formed. From these data, it appears that these interactions will vary 
considerably during healing, in accordance with our hypothesis that healing can be 
manipulated by altering the mechanical properties of the fixator after healing has 
begun.    
 
In the next chapter I test this hypothesis more directly by investigating the effects of 
the mechanical environment upon healing critical size segmental femoral defects in 
response to rhBMP-2 in the in-vivo rat model using new generation external fixators 
with different stiffnesses. 
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CHAPTER FOUR 
 
 
Investigation of the effect of the mechanical environment on the healing of an 
experimental, critical sized femoral defect in response to rhBMP-2. 
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4.1 INTRODUCTION 
 
The design, construction and thorough in-vitro mechanical characterization of the 
new, novel external fixators, where described in the previous two Chapters. These 
novel external fixators were tested in an in-vivo experimental femoral CSD rat 
model, where healing was initiated by rhBMP-2 treatment. The outcomes were 
compared with “first generation” ExFixOld fixator used in our laboratory for various 
previuos in-vivo experimental studies, and for which we have considerable historical 
data.  
 
BMP-2 protein was chosen to enhance healing process because of the wide use in 
animal experimental studies and several clinical trials where has been shown that 
BMP-2 and BMP-7 was able to repair segmental defects, non-unions and delayed 
unions. Furthermore, a sudy by Tsuji et al. [74] reported that BMP-2 is a necessary 
component of the signalling cascade for initiating fracture healing. They found that 
mice lacking to produce BMP-2 protein in the limb bone have spontaneous fractures 
that do not heal at any time point. In fact, the absence of BMP-2 in bone seems to 
block the earliest steps in fracture healing. Although, other osteogenic stimuli such 
as BMP-4 and 7 were still present in a limb of BMP-2 deficient mice, they could not 
compensate for the absence of BMP-2. In addition, this protein has been clinicly 
approved for the treatment of acute tibial fractures in adults as an adjunct to standard 
care (see more details in Chapter One, section: Current Clinical Management of 
Large Segmental Defects). 
 
As mentioned in the general introduction, in our laboratory, rat CSDs healed 
inconsistently and did not provide optimal healing in response to BMP-2, whether 
delivered as a protein or a gene (cDNA). As noted in the previous Chapter, ExFix 
Old stability bar is very stiff and in many rats, bone mineralization failed to occur on 
the cortical surface facing the fixator even as bone was accumulating on the opposite 
surface. Figure 4.1 shows that there is variability in the pattern of bone defect 
healing in the group treated with rhBMP-2 [60].  
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Figure 4.1 Representative 3D (top row) and 2D (second row) longitudinal and transverse 
(third row) µCT images of femur after 8 weeks of treatment with rhBMP-2 with an external 
fixator (ExFixOld) and contralateral, intact femur. 
 
While one of the images (Figure 4.1, rhBMP-2 C) show complete healing of the 
defect with defined cortical and trabecular bone after 8 weeks of treatment, the other 
two defects have incomplete healing, including the presence of soft tissue (Figure 
4.1, rhBMP-2 A&B) and one of them developed pseudoarthrosis or so called “fake 
joint” (Figure 4.1, rhBMP-2 A). This variability is probably due to the increased 
IFM caused by insufficient stability provided by the old external fixator in the initial 
phase of bone repair. In chapter three I described the mechanical environment 
created by this external fixator in-vitro in axial compression, which is a simulation of 
weight bearing. Interestingly, while the old external fixator implanted on the rat 
femur in-vitro was very stable and rigid on the intact rat femur, as soon as the defect 
was created the construct became very unstable, probably due to the large 25mm 
offset from stability bar to the bone surface, which might have made defect site 
unstable. In addition, K-wires were used to stabilize CSD they are not very rigid and 
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this might have caused rotational instability. Molster et al [93] and other 
investigators [92, 122, 123] have shown that great rotational instability or shearing 
movements were detrimental to the process of fracture healing and prolonged the 
maturation of external callus.  
 
Collectively, these observations led to the hypothesis that healing of a critical-sized 
segmental defect under the influence of rhBMP-2 is exquisitely sensitive to the local 
mechanical environment; as noted, this hypothesis forms the basis of the current 
project. Therefore, a primary goal for this part of the study is to understand better the 
role of the mechanical environment in the induced healing of critical-sized segmental 
bone defects in long bones with various stiffness external fixator in-vivo. To test this 
hypothesis I investigated bone healing using my newly developed external fixators, 
in conjunction with a 5 mm segmental bone defect in the rat femur. Healing was 
initiated with rhBMP-2 to determine the effects of different stiffnesses on healing 
and compared to the data from the ExFixOld fixator used in our laboratory.  
 
 
 
4.2 MATERIALS AND METHODS 
 
4.2.1 In-Vivo Studies - Study design 
 
A 5 mm, critical sized mid-diaphyseal femoral defect was created in the right hind 
limb of each of 45 male Sprague-Dawley rats (weight 325-360 g) and stabilized by 
an external fixator [54] with one of the three stiffnesses described in Chapter 2. The 
rats were assigned to one of four groups.  
Group   one: Empty Control (n=3) ExFixHigh 
Group   two: Empty Control (n=3) ExFixMed 
Group three:  Empty Control (n=3) ExFixLow 
Group   four: rhBMP-2 (11 µg) ExFixHigh (n=12) 
Group   five: rhBMP-2 (11 µg) ExFixMed (n=12) 
Group   six: rhBMP-2 (11 µg) ExFixLow (n=12) 
  
The number of control animals in groups 1-3 was low because of extensive historical 
data confirming that these defects do not heal spontaneously [54, 62]. The numbers 
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of animals in the treatment groups were based upon historical data confirming 
sufficient statistical power [54]. The concentration of BMP-2 we used is based upon 
the data of Yasko et al. [61] and our previous experience in using rhBMP-2 in this 
model [60]. BMP-2 was delivered on absorbable collagen sponges that form part of 
the system, “Infuse” (Medtronic).  
 
In all groups, treated femora were compared to the intact, contralateral femur. 
Healing was monitored by weekly radiologic evaluation. Eight weeks after surgery, 
final X-rays were taken and animals euthanized. The amount and quality of healed 
bone defects were evaluated by dual-energy X-ray absorptiometry (DXA), micro-
computed tomography (µCT), histology and torsional mechanical testing. All 
specimens were subjected to the non-destructive analyses, DXA and µCT. 
Subsequently, 2-3 femora per group were randomly selected and fixed for histology 
in 4 % ice cold paraformaldehyde. The remaining specimens were wrapped in the 
gauze, soaked with 0.9% saline solution and frozen at -20ºC for mechanical testing.  
 
 
4.2.2 Surgical Procedure 
 
Animal care and experimental protocols were followed in accordance with NIH 
guidelines and approved by the Beth Israel Deaconess Medical Center Institutional 
Animal Care and Use Committee. Following a minimum 48-hour acclimatization 
period, the animals were transported to a dedicated surgical procedure room. All the 
animal surgeries were performed as described in chapter two, section 2.3.2 page 48. 
 
 
4.2.3 Implants 
 
Recombinant, human BMP-2 was delivered on absorbable collagen sponges, Infuse, 
obtained from Medtronic (Minneapolis, MN, USA). These were cut under sterile 
conditions to a length of 1.0 cm to produce a dry implant volume of 0.33 ml. The 
rhBMP-2 at a dose of 11 µg (Medtronic) was applied to the collagen sponge, in a 
total volume of 200 µl PBS and allowed to soak into the sponge for at least 15 
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minutes, prior to implantation. Only PBS was delivered on absorbable collagen 
sponge in a total volume of 200 µl for the empty control group. 
 
 
4.2.4 External Fixators 
 
Novel, external fixators of stiffnesses 114±1.14 (ExFixLow), 185±6.14 (ExFixMed) 
and 254±9.54 N/mm (ExFixHigh), described in Chapter 2, were used for this set of 
experiments. Characteristics of the “first generation” external fixator, ExFixOld, are 
also described in chapter 2. More detailed in-vitro mechanical characterization of 
these external fixators is described in chapter three.  
 
 
4.2.5 Radiographic Evaluation 
 
Bone healing was evaluated by radiograpy once per week for 8 weeks using a digital 
dental X-ray unit (Heliodent DS, Sirona, Germany). While under general anesthesia, 
the rats were placed in a ventral position and the hind limb was laterally rotated so 
that the external fixator was not in the path of the X-ray source. While I didn’t have 
a jig for standard positioning of hind limb for weekly X-rays, I was carefull to take 
weekly X-rays in exact orientation as in the previous week. Each radiograph were 
examined by me in a “semi-blided” way, which means that I did know the ID 
number for each animal, but didn’t know in which experimental group they belonged 
and gave a score depending on the amount of bone that had formed. All femurs were 
evaluated for radiographic evidence of healing, using a graded scoring system (0, 
minimal to no evidence of new bone formation; 1, evidence of bone formation, 
complete healing questionable; 2, solid-appearing bone, complete healing) [54, 124]. 
The defect was considered united when the osseous continuity of the femur was 
restored across more than 25 per cent of the cross-sectional diameter of the defect, as 
determined radiographically. There are of course the limitations of not having an 
independent observer reading the radiographs. Since I was the one who took weekly 
X-rays I might have been byass in the scoring process. 
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4.2.6 Dual-Energy X-Ray Absorptiometry (DXA)  
 
We assessed the bone mineral content (BMC g) of the defect region by dual-energy 
X-ray absorptiometry (PIXImus 2, GE-Lunar, Madison, WI). Specimens were placed 
on a lucite block during scanning to simulate soft tissue. The scans were acquired 
using small animal high-resolution mode. All excised femurs were evaluated after 8 
weeks of treatment in the area corresponding to the region of the critical-sized 
segmental bone defect.  The DXA machine is calibrated yearly by the manufacturer. 
 
 
4.2.7 Micro-Computed Tomography (µCT)  
 
All femurs were scanned using a desktop micro-tomographic imaging system 
(µCT40, Scanco Medical AG, Bassersdorf, Switzerland) equipped with a 10 mm 
focal spot microfocus X-ray tube. Femora were scanned using a 20µm isotropic 
voxel size, at 55keV energy, 200ms integration time, with approximately 720 µCT 
slices per specimen. Evaluation was done only in the 4mm (200 slices) central defect 
region to ensure that no pre-existing cortical bone was included in the analyses 
(Figure 4.2). This was standardized by excluding 10 slices from proximal and distal 
sides at the cortical edge of created defects. To evaluate the region of interest we 
assessed the following variables: total cross-sectional area or the callus size of the 
defect (TA, mm²), bone area (BA, mm²) and bone area over total area (BA/TA, 
mm²). Polar moment of inertia (pMOI, mm4) was also calculated from µCT images. 
Images were thresholded using an adaptive-iterative algorithm and morphometric 
variables were computed from the binarized images using direct, 3D techniques that 
do not rely on any prior assumptions about the underlying structure [125-127].  
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Figure 4.2 Micro-computed tomography images showing evaluation of central defect after 8 
weeks of treatment: (A) longitudinal 3D view of sample of non-healed defect from the 
Empty Defect group shows region of interest analyzed between the two white lines; (B) Red 
line represents contour around external callus from 2D transverse section, in the middle of 
the healed defect from one of the sample treated with rhBMP-2. All the data presented were 
calculated within the red line. 
 
 
 
4.2.8 Histology 
 
After evaluation by µCT and DXA the specimens were decalcified 6-8 hr in RDO 
Rapid decalcifier (Apex Engineering, Aurora, IL), testing with a needle as the 
decalcification proceeded. 
 
Fixed and decalcified tissues were dehydrated in graded ethanols up to 100%, 
transferred to xylene, and embedded in paraffin. Five-micron paraffin sections were 
placed on poly L-lysine coated slides, dried overnight and evaluated immediately or 
stored at 4˚C. Sections were stained with hematoxylin-eosin to determine general 
morphology and safranin orange-fast green to detect cartilage. Safranin O is a 
nuclear stain, which produces red nuclei and used as a counter stain. 
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4.2.9 Ex-Vivo Torsion Testing 
 
After all noninvasive imaging was completed, 7-8 specimens per group were tested 
to failure in torsion to determine the mechanical properties of the healed defect in 
shear. Before the test both ends of each specimen were embedded in 
polymethylmethacrylate (PMMA) to provide a reproducible gripping interface with 
the testing fixture. All femora were tested to failure under regular deformation 
control and at the constant deformation rate of 5 rad/min. Angular deformation and 
applied load data were acquired at 10Hz. The torque and rotation data were used to 
calculate the torsional stiffness and strength of the healed defect.  
 
Before the actual bone testing was executed, a validation test was performed to make 
sure that the mechanical test system was calibrated. Plexiglas rods were used for the 
calibration. This material was chosen because it has similar behavior to bone tissue 
and therefore is suitable for this purpose. The material properties for this material 
was obtained from the supplier (McMaster-Carr, NJ, USA). The Plexiglas rods used 
for the validation test were embedded using the same procedure as the bone 
specimens. The same test parameters were used for the torsion test. The strain rate 
was chosen at 5 rad/min, which resulted in the material workstation crosshead speed 
of 75mm/min. The results from the test were very close to the values that were 
provided by the manufacture. Therefore, it was determined that the system is 
functional and accurate for bone testing. 
 
 
4.2.10 Statistical Analysis 
 
Comparisons of continuous variables between two treatment groups were performed 
using a two-tailed t-test, and between three groups by analysis of variance (One 
Way-ANOVA). If the difference between the contralateral femur and the treatment 
groups was significant, a posthoc test (Tukey) was performed. A power analysis 
after the study was calculated to determine if we had sufficient animals per group for 
significant difference. The power level for all the data was found to be from 0.8 to 1. 
Thus the numbers of animals per group used in these studies is enough to determine 
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a 5% difference between the test groups. All tests were two-tailed, with differences 
considered significant at p<0.05. Data are presented as mean±SE, unless otherwise 
noted. 
 
 
 
4.3 RESULTS 
 
4.3.1 Radiographic Evaluation 
 
Weekly X-rays revealed that bone callus size was biggest in the group with the 
lowest stiffness fixator. Furthermore, early mineralization of the callus was seen in 
this group and in the medium stiffness group after 9 days of treatment. However, the 
group with the highest stiffness external fixator had no callus formation at this time; 
indeed callus formation was delayed until after two weeks of treatment. By the third 
week defects were bridged regardless of the fixation methods, with the biggest callus 
being in the groups with low and medium stiffness fixators and the smallest callus in 
the group with the highest stiffness (Figure 4.3A&B). No bone formation was seen 
by X-ray at any time point in any of the animals lacking rhBMP-2. 
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Figure 4.3A First set of representative radiographic images with low, medium and high 
stiffness external fixators after 9 days, and 2, 3, 4, 5, 6, 7 and 8 weeks of treatment with 
rhBMP-2. Defects without rhBMP-2 (Control Group with ExFix40%) did not heal no matter 
what stiffness fixator was used. 
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Figure 4.3B Second set of representative radiographic images with low, medium and high 
stiffness external fixators after 9 days, and 2, 3, 4, 5, 6, 7 and 8 weeks of treatment with rhBMP-
2. Defects without rhBMP-2 (Control Group with ExFix40%) did not heal no matter what 
stiffness fixator was used. 
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4.3.2 Dual-Energy X-Ray Absorptiometry (DXA)  
 
After 8 weeks of treatment bone mineral content (BMC, g) was highest with 
ExFixLow as compared with all the other groups, exceeding that of the contralateral 
femur. This was statistically significant when compared to the contralateral femur 
and ExFixOld, but there was no satistically significant difference between ExFix 
Low and ExFixMed and ExFixHigh, although there was a trend downward with the 
two higher stiffness fixators. Also, there was no difference between intact 
contralateral femur and ExFixOld. (Figure 4.4 and table 4.1 and 5.3). 
 
            
 
Figure 4.4 Bone mineral content (BMC, g) in the segmental defect region after 8 weeks of 
treatment with rhBMP-2 as measured by DXA. Values given are means ± SEM; Asterisks 
indicate statistically significant from intact, contralateral femur, dollar signs indicate 
statistical significant difference from ExFixOld, and pound signs indicate significant 
difference from ExFixHigh (p < 0.05, n=9-10 per group).  
 
 
Table 4.1 Bone mineral content segmental healing characteristic of intact femur, ExFixOld, 
ExFixLow, ExFixMed and ExFixHigh treated with rhBMP-2 as measured by MicroCT 
(mean ± SD). Asterisks indicate statistical significance from intact, contralateral femur, 
Variables Intact Femur (n=10) 
ExFixOld 
(n=10) 
ExFixLow 
(n=10) 
ExFixMed 
(n=9) 
ExFixHigh 
(n=9) 
      
BMC (g) 0.075±0.01# 0.076±0.01# 0.099±0.02*$ 0.091±0.02*$ 0.091±0.03*$ 
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dollar signs indicate statistical significant difference from ExFixOld, and pound signs 
indicate significant difference from ExFixHigh (p < 0.05, n=9-10 per group). 
 
 
4.3.3 Micro-Computed Tomography (µCT) 
 
Quantitative analysis of the µCT data confirmed the radiographic images. The total 
cross-sectional area (TA, mm2) or callus size in the ExFixOld group was three times 
bigger than the intact contralateral femurs, (p < 0.0001) (Figure. 4.5, Table 4.2 and 
5.3). The intact contralateral femur was also significantly lower in cross-sectional 
area when compared to ExFixLow, ExFixMed and ExFixHigh; this difference was 
57, 48 and 41% respectively, (p < 0.0001). Furthermore, there was a gradual 
decrease in cross sectional area from the ExFixOld group when compared to the 
other ExFix groups, and this difference was statistically significant, (p < 0.0001) as 
shown in the figure 4.5. Defects in groups lacking rhBMP-2 had no callus formation 
and were significantly different from the other groups and the contralateral femur, (p 
< 0.0001), (data not shown).  
 
                       
 
Figure 4.5 MicroCT was used to measure Total Area/callus (mm2) with four different 
stiffness fixators (mean ± SEM). Asterisks indicate statistical significance from intact, 
contralateral femur, dollar signs indicate statistical significant difference from ExFixOld, 
and pound signs indicate significant difference from ExFixHigh (p < 0.05, n=9-10 per 
group).  
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Bone area (BA, mm2) in the defect region in all the groups was at least 30% higher 
than in the intact contralateral femurs, (p < 0.003). The smallest amount of bone was 
seen in the ExFixOld group; however, a statistically significant difference was only 
seen when compared with ExFixLow fixator (p < 0.004, Figure 4.6, Table 4.2 and 
5.3). Interestingly, the same group had the highest amount of bone and this 
difference was at least 12%.  
 
 
                   
 
Figure 4.6 MicroCT was used to measure Bone Area (mm²) following healing in the 
presence of rhBMP-2 under the influence of fixators with four different stiffnesses (mean ± 
SEM). Asterisks indicate statistical significance from intact, contralateral femur, dollar signs 
indicate statistical significant difference from ExFixOld, and pound signs indicate 
significant difference from ExFixHigh (p < 0.05, n=9-10 per group).  
 
 
Bone area/Total Area (BA/TA, %) the so called bone area fraction, which reflects 
callus size in the defect region was lower in all different stiffness external fixator 
groups compared to the intact contralateral femurs, (p < 0.008). The lowest BA/TA 
was seen in the ExFixOld group and it was significantly different from all other 
groups (p < 0.006, Figure 4.7, Table 4.2 and 5.3). Interestingly, the ExFixMed and 
ExFixHigh groups had almost the same amount of bone as intact contralateral femur.   
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Figure 4.7 MicroCT was used to measure Bone Area/Total Area (%) with four different 
stiffness fixators across defects treated with treated with rhBMP-2 (mean ± SEM). Asterisks 
indicate statistically significant differences from intact, contralateral femur. Dollar signs 
indicate statistical significant difference from ExFixOld, and hash signs indicate significant 
difference from ExFixHigh (p < 0.05, n=9-10 per group).  
 
 
The polar moment of inertia (pMOI, mm4) is a quantity used to predict an object’s 
ability to resist torsion. The larger the pMOI, the less the beam will twist, when 
subjected to a given torque. The polar moment of inertia (pMOI, mm4) was at least 
twice as big in all the groups when compared to the intact contralateral femurs, (p < 
0.0001) (Figure. 4.8, Table 4.2 and 5.3). The ExFixOld created the biggest pMOI 
when compared with other external fixators, with a gradual downward decrease as 
the stiffness of the fixator increased. The pMOI was not statistically different from 
the ExFixOld compared to ExFixLow, but it was statistically significant from 
ExFixMed and ExFixHigh. The ExFixMed and ExFixHigh were not statistically 
different from each other. 
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Figure 4.8 MicroCT was used to measure polar moment of inertia (pMOI, mm4) with four 
different stiffness fixators treated with rhBMP-2 (mean ± SEM). Asterisks indicate statistical 
significance from intact, contralateral femur, dollar signs indicate statistical significant 
difference from ExFixOld, and hash signs indicate significant difference from ExFixHigh (p 
< 0.05, n=9-10 per group).  
 
 
The results of the physical testing are collated in Table 4.2 
 
 
 
Table 4.2 Segmental healing characteristics of Intact femur, ExFixOld, ExFixLow, 
ExFixMed and ExFixHigh treated with rhBMP-2 as measured by MicroCT (mean ± SEM). 
Asterisks indicate statistical significance from intact, contralateral femur, dollar signs 
indicate statistical significant difference from ExFixOld, and hash signs indicate significant 
difference from ExFixHigh (p < 0.05, n=9-10 per group).  
 
Variables Intact Femur (n=10) 
ExFixOld 
(n=10) 
ExFixLow 
(n=10) 
ExFixMed 
(n=9) 
ExFixHigh 
(n=9) 
      
TA 
(mm²) 12.7±0.3
# $ 35.6±2.8*# 29.8±1.5*# $ 24.4±2.0*$ 21.5±2.1*$ 
BA 
(mm²) 8.3±0.2
# $ 11.7±0.5* 15.8 ± 1.3*# $ 13.8 ± 1.4*$ 12.8 ± 1.2*$ 
BA/TA 
(%) 65.1±0.9 
$ 34.8±3.2*# 53.6±4.1$ 59.6±7.6 $ 62.4±6.4 $ 
pMOI 
(mm4) 23.1±1.2
# $ 89.2±9.0*# 85.9±3.5*# 61.8±8.2*$ 54.4±8.1*$ 
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The bone architecture of three different stiffness fixator groups differed from that of 
the intact, contralateral femur, at 8-weeks treated with rhBMP-2. Figure 4.9A&B 
shows representative longitudinal images from the µCT analysis. These confirm 
healing of the defects in the presence, but not the absence, of rhBMP-2 no matter 
what stiffness fixator was used. There was no evidence of healing in the untreated 
defects.  
                   
 
 
Figure 4.9A First set of representative (each sample was selected as an overall mean from 
each group) 3D (top row) and 2D (second and third rows) longitudinal µCT images of 
femora after 8 weeks of treatment with rhBMP-2 and three different stiffness fixators. 
 
 
Figure 4.10A&B shows representative transverse images that confirm the presence 
of an intact cortex in the healed bones, and the presence of trabecular bone within 
the marrow of bones when treated with rhBMP-2 despite the type of external fixator 
used. It also shows a different pattern of bone healing in the defect region produced 
by the three different stiffness fixators. Interestingly, the thickest cortex and the 
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biggest amount of trabecular bone formed was observed with the most rigid external 
fixator (ExFixHigh), yet this group had the smallest callus size. As mentioned earlier 
the biggest callus was formed with the most flexible external fixator (ExFixLow), 
but this group had the thinnest cortex, but not the smallest amount of bone. The 
middle stiffness fixator group had the least amount of trabecular bone, but the 
thickness of cortical bone formed was intermediate.  
 
 
 
    
 
Figure 4.9B Second set of representative (each sample was selected as an overall mean from 
each group) 3D (top row) and 2D (second and third rows) longitudinal µCT images of 
femora after 8 weeks of treatment with rhBMP-2 and three different stiffness fixators. 
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Figure 4.10A First set of representative transverse 2D µCT images of femur after 8 weeks 
of treatment with rhBMP-2 and three different stiffness fixators: top row-distal part of the 
defect; middle row-middle of the defect; bottom row-proximal part of the defect.  
 
                                              
Chapter Four
 
 
 107 
Figure 4.10B Second set of representative transverse 2D µCT images of femur after 8 
weeks of treatment with rhBMP-2 and three different stiffness fixators: top row-distal part of 
the defect; middle row-middle of the defect; bottom row-proximal part of the defect. 
 
 
4.3.4 Histology 
 
The histological findings (Figure.4.10) were consistent with the imaging data. There 
was no evidence of bone formation in the groups without rhBMP-2 and a complete 
transverse separation of the diaphysis in the defect region no matter which stiffness 
fixator was used. Moreover, the defect region was filled with layer of fibrous 
connective tissue continuous with the periosteum lining the cortices on the outer 
surface adjacent to the defect (images not shown).  
 
There was periosteal and medullary bone formation in the defect region in the groups 
treated with rhBMP-2 regardless of the fixator stiffness. In these groups the entire 
defect was filled with well-differentiated islands of bone. Furthermore, there were 
mild to moderate zones of woven bone along the cortices proximal and distal to the 
segmental defect region, but with no obvious differences qualitatively between the 
treatment groups. The defects treated with ExFixLow had the biggest callus as 
compared to the ExFixMed and ExFixHigh, which supports the imaging data. 
Interestingly, ExFixMed and ExFixHigh groups had persistence of cartilage as 
shown by safranin orange staining, which could not be seen in the x-ray and µCT 
images. The group with the ExFixLow had no residual cartilage (Figure 4.11, bottom 
row). 
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Figure 4.11 Representative longitudinal histological sections of femoral segmental defects 
after 8 weeks of treatment with rhBMP-2 with three different stiffness fixators. Paraffin 
embedded sections were stained with Hematoxylin & Eosin (rows one and two) and 
Safranin Orange-Fast Green (rows three and four). Magnification for rows one and three is 
16x, and rows two and four 25x). 
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4.3.5 Ex-Vivo Torsion Testing 
 
Torsional testing was used to determine the mechanical properties of critical sized 
segmental defects treated with rhBMP-2 using four various stiffness external 
fixators: ExFixOld, ExFixLow, ExFixMed and ExFixHigh groups and compared to 
those of the intact contralateral femur. Torsional stiffness measurements revealed 
that ExFixLow produced a statistically significant increase in stiffness compared to 
intact contralateral femur, ExFixOld and ExFixHigh, this increase was 29%, 24%, 
24%, respectively p<0.047 (Figure 4.12 and Table 5.3). The difference between the 
stifnesses generated by ExFixLow and ExFixMed was not statistically significant 
p<0.07.  
 
 
                               
 
Figure 4.12 Torsional stiffness of femurs treated with rhBMP-2 with four different stiffness 
fixators treated with rhBMP-2 after 8 weeks (mean ± SEM). Asterisks indicate statistical 
significance from ExFixLow (p < 0.05, n=7-8 per group).  
 
Interestingly, the maximum torque was not different between the groups. However, 
there was a trend reflecting the torsional stiffness data, where defects healed in the 
presence of ExFixLow needed the most force to fail (Figure 4.13 and Table 5.3). 
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Figure 4.13 Maximum Torque to failure of femurs treated with rhBMP-2 with four different 
stiffness fixators treated with rhBMP-2 after 8 weeks (mean ± SEM, p < 0.05, n=7-8 per 
group).  
 
 
4.3 DISCUSSION 
 
This study and others have shown that rhBMP-2 promotes bone formation and the 
healing of CSDs in animal models [17, 58-61, 112, 128-130]. However, many 
studies show that the healing of segmental CSD under these conditions is subject to 
variability and the new bone has poor quality compared to normal bone. For reasons 
discussed earlier in this thesis, this is likely to be related to the stability of CSD 
fixation. In addition other factors such as weight bearging of the animal, muscle 
loads will also influence healing of defects, however this was not addressed in this 
thesis. 
 
The radiographic data obtained in this study demonstrate that the stiffness of the 
external fixator can have a marked effect on healing, especially at early time points. 
Indeed, a difference in the femoral defect repair pattern was already evident nine 
days post-surgery, at which time defects fixed with the two least rigid external 
fixators showed evidence of bridging mineralization. Interestingly, this always 
occurred initially on the side of the defect that was opposite the fixator. Neither the 
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fixator (ExFixHigh) imposing the highest rigidity at early time points, nor the fixator 
(ExFixOld) imposing the lowest rigidity at early time points produced a radioopaque 
line at this time. This finding is consistant with the hypothesis that mesenchymal 
cells commit to either a chondrogenic or an osteogenic lineage during the first few 
days of healing depending on the mechanical environment [131].  
 
By the week two there were signs of new bone formation and bony bridging in all 
defects, regardless of the stiffness of the fixators. However, the most rigid fixator 
produced a smaller callus than the other two lower stiffness fixators, which supports 
existing data in the literature. Furthermore, the radioopaque line was still seen by the 
third week post surgery, but by week four all groups had complete bone defect 
bridging as assessed by X-ray. At the end of the eight week experiment all defects 
had complete healing no matter which stiffness fixator was used, although the 
defects stabilized with the most rigid fixator had smaller callus than those stabilized 
with lower stiffness fixators. 
 
The radiographic observations were supported by additional imaging analyses. Dual-
energy X-ray absorptiometry, for example, showed that bone mineral content was 
significantly different from the intact contralateral femur no matter which stiffness 
external fixator was used. Furthermore, this significant difference was also seen 
when the ExFixOld was compared to the new fixators, but it was not different from 
the intact contralateral femur. In addition mCT revealed that the biggest callus and 
the greatest amount of new bone was formed with the lowest stiffness, ExFixLow, 
fixator. Furthermore, the ExFixMed and ExFixHigh showed no difference when 
compared to each other. Not surprisingly, ExFixOld produced the biggest amount of 
callus, but the amount of new bone formed within the callus was only comparable to 
the new most rigid fixator, ExFixHigh. This is probably related to the higher axial 
intrafragmentary movement related to the poor stability of ExFixOld in the early 
stages of defect healing and supports my findings from the axial compression in-
vitro test where it showed that after 5mm defect was created in the constructs with 
ExFixOld, they became unstable, which would have increased the IFMs in an in-
vivo setting. On the contrary, after the harder material was used which simulated 
final stages of healing, the ExFixOld became rigid again, which in turn would have 
deacreased the IFMs in the in-vivo situation. This finding partially explains 
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comparebable amounts of healed bone in the callus between ExFixOld and 
ExFixHigh, because after the IFMs have decreased, the callus tissue began to 
remodel by resorbing trabecular bone formed as part of the process in the 
regeneration of bone tissue. 
 
 These observations support a number reports in the literature that have shown that 
the healing of long bone fractures and callus size is sensitive to the axial 
intrafragmentary movement or the axial fixation stability [65, 73, 132, 133]. 
Furthermore, the µCT images of longitudinal and transverse sections showed the 
presence of soft tissue in the healed defect when the most rigid fixator, ExFixHigh, 
was used (Figure 4.9A&B and 4.10A&B). These data are supported by the 
histological images, which demonstrated persistent cartilage 8 weeks post-surgery 
using ExFixMed and ExFixHigh. This is contradictory to the reported influence of 
mechanical conditions on fracture healing, where less stable fixation has been shown 
to have cartilage that persists longer before ossifying, and illustrates the need for 
caution when extrapolating from concepts derived from studies of fractures that 
spontaneously heal to CSDs, which do not. Nevertheless, the larger callus seen with 
ExFixLow is in agreement with previous observations that less stable fixation 
produces greater amount of cartilage leading to a larger soft callus [41, 81, 88, 92, 
106, 108, 120, 134-136]. In addition, the histological findings from the present study 
suggest that segmental defects treated with rhBMP-2 and stabilized with ExFixMed 
and ExFixHigh heal through endochondral ossification. This process appears to be 
influenced by the fixation stability, although the exact mechanism is not clear and 
requires further study. 
 
Biomechanical torsional testing of femora at 8 weeks revealed significantly higher 
stiffness with ExFixLow when compared to the intact contralateral femurs and all 
other stiffness fixators. This finding compliments the study by Epari et al. [136] 
where they examined the interaction between the axial and shear components of the 
fixation stiffness in the osteotomy sheep model. They found that axial stiffness 
together with high shear stiffness provides excellent healing. Furthermore, if axial 
stiffness is either increased or decreased from the moderate range, the strength and 
stiffness of the callus is reduced despite only a marginal change in the shear 
stiffness, as in cases of rigid and semi-rigid fixators.   
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The maximum torque at which femurs broke under torsion followed the same pattern 
as the stiffness, but there was no significant difference between the different fixators. 
It is possible that the healed defects converged on a common strength by various 
combinations of callus size and bone area. For example, when ExFixOld was used 
the healing defects formed the biggest callus, but had the least amount of new bone. 
The new external fixators produced smaller calluses but larger amounts of new bone. 
 
These findings are consistent with those of other investigations who found that 
fixation stability and applied loads determines intrafragmentary movements, which 
influence the pattern of bone healing [41, 65, 66, 71, 81, 91, 98, 135-145]. 
Insufficient shear stability has been shown to delay fracture healing by disrupting the 
blood supply [146]. This may partially explain the bigger callus and the smaller 
amount of new bone formed with the old external fixator stabilized with K-wires. 
This also was shown in an in-vitro axial compression test where the rubber material 
was inserted into the critical-sized segmental defect. This construct had the lowest 
stiffness, probably due to rotational instability caused by high shear intrafragmentary 
movements. Furthermore, it has been shown that in the segmental CSDs, K-wires do 
not provide sufficient stability and particularly almost no rotational stability is 
achieved [59, 92]. The exact mechanism cannot be explained by this study.  
 
In Conclusion, this is the first study to confirm the importance of the mechanical 
environment on the healing of critical sized segmental defects treated with rhBMP-2, 
therefore a careful consideration is needed when selecting the fixation device. Some 
of the data suggest that the mechanical influence on the healing of CSDs differs from 
its influence on fracture healing, indicating the need for separate investigation of the 
two. This realisation could help to define the mechanical environment for healing 
CSDs using BMPs in the most efficient and timely manner. By carefully selecting 
the fixator stiffness, optimizing the fixator stiffness and determining the optimal time 
point to change the stiffness of the fixator in-vivo as the healing progresses. These 
factors might reduce the requirement for high doses of BMPs, which are currently 
used. Studies towards achieving this aim will be described in the next chapter.  
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CHAPTER FIVE 
 
 
The development of a modulated mechanical environment for bone healing in 
the rat segmental defect model        
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5.1 INTRODUCTION 
 
Bone repair involves interactions of cells within local mechanical environments that 
generate a cascade of molecular events resulting in the repaired and remodelled bone 
tissue at the fracture site [38, 147, 148]. It has been long recognized that the 
formation of cartilage and bone, as well as the architecture of the bone laid down 
during bone healing in response to normal activity such as weight-bearing, is 
influenced by the local mechanical environment. If there is excess motion at the 
injury site, the principal mechanism of bone regeneration is through secondary or 
endochondral ossification, or the formation of cartilaginous callus, which is 
gradually replaced by new bone. The majority of clinical fractures heal by secondary 
union or endochondral ossification where a certain amount of micromotion at the 
fracture site is necessary to stimulate the formation of callus. 
 
The data from the previous chapter suggest that there is not one set of mechanical 
circumstances that suits all stages of healing, and that healing might be improved by 
changing the stiffness of the fixator as healing progresses. Previous investigators 
have attempted to achieve this by the dynamization of operatively stabilized 
fractures [35, 83, 98, 139, 140, 142, 149-152]. Dynamization is a word used when 
the IFM is increased by changing from rigid fixation to a more flexible fixation. It is 
also used when an implant allows axial shortening of a bone through a telescoping 
mechanism incorporated into the fixation device. In this study I use dynamization in 
the first sense.  
 
Although several fracture fixation devices have been developed that allow 
dynamization in the clinical treatment of fractures, it remains unclear at which time 
during the healing process the dynamization should be applied and whether it helps 
fractures to repair more efficiently. Unfortunately, few clinical studies have 
attempted to determine the optimal axial IFM or the effect of dynamization at the 
various stages of fracture repair, and it is unclear whether this accelerates bone repair 
in a more efficient and timely manner [152-154]. There are no studies to my 
knowledge that have attempted to determine the effects of dynamization on the 
healing of CSDs.  
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The results of animal studies on the effects of dynamization on fracture healing are 
inconsistent. A study by Larsson et al [151] investigated the effect of early axial 
dynamization on tibial bone healing in a canine model. They used a rigid external 
fixator to stabilize 2mm transverse osteotomy on both tibias in each dog to allow 
paired comparison of the results. One week after the surgery, the telescoping 
mechanism of one randomly selected fixator on each dog was unlocked to allow free 
axial movement where as the other side was kept rigidly fixed throughout the study. 
Animals where sacrificed at 1, 3, 5, 8 and 11 weeks after dynamization. They found 
that early dynamization resulted in accelerated callus formation, maturation and in 
increased remodelling of endosteal and periosteal callus tissue. Moreover, the 
dynamized side showed significantly higher torsional stiffness after 5 weeks of 
treatment than did the controls. In addition, a study by Aro et al. [83] also 
investigated bone healing pattern affected by loading, fracture fragment stability, 
fracture type and fracture compression in a canine osteotomy model. This study had 
three different groups; they looked at transverse and oblique fractures fixed with a 
rigid unilateral external fixator with the cut ends of the bone separated by a distance 
of 1 or 2mm, or in a contact. Dynamization of uniform axial loading and motion was 
performed at two or four weeks. They found that, at the given rigidity of external 
fixation, the amount of physiologic stresses and the presence of a significant gap 
proved to be the most significant factors in determining the pattern of fracture repair. 
Motion with loading tended to promote external callus maturation in secondary bone 
healing.  
 
On the contrary, two studies in a rat model found that neither early nor late fracture 
dynamization was beneficial to fracture healing. Although they used different 
fixation devices such as a rigid nail [98] and an external fixator [149] and initiated 
dynamization either at the later or earlier healing phase, both groups found that 
dynamization increased callus formation, but the quality of healed bone was reduced. 
These findings are not really surprising knowing that the evidence in the literature 
show that increased IFM resulting from the flexible fixation device leads to bigger 
callus formation, prolonged chondral phase and delayed bone healing by disrupting 
the vascular supply needed for bone tissue to repair and remodel (Rand et al, Ozaki 
et al). In fact, a study by Culinane et al. [139] tried to regenerate a complete joint by 
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precisely controlled motion using a custom made external fixator and introducing 
IFM bending strain and comparing this to the rigidly fixed segmental defect. The 
results of the study showed that although joint development was incomplete, they 
were able to direct formation of cartilage and bone during fracture repair by inducing 
controlled motion. They also have demonstrated, that the spatial organization of the 
molecular components within the newly formed tissue is influenced by the local 
mechanical environment and if the IFM is too high, bone does not form.   
 
Augat et al (1996) confirmed that increased flexibility at the fracture site results in 
enhanced callus proliferation and that increased callus volume was not necessarily 
associated with increased mechanical quality of the healed bone. They found that an 
extension in diameter of callus increased the flexural rigidity of the fracture only if 
the quality of tissue remained the same. In addition, in the previous chapter I showed 
that earlier and bigger callus was formed with more flexible external fixators and 
that these produced bone with a higher bone mineral content. This is probably due to 
a delayed remodelling process, which could make the tissue of bone more brittle. On 
the contrary, a more rigid fixation device had later callus formation with less 
mineralized bone tissue at the end of 8 weeks treatment. This leads to a postulation 
that the cartilage in the callus is calcified and remodelled into bone tissue only after 
reduction of local strains or so called axial IFM at the surface of new bone 
formation. 
 
Knowing this, I hypothesize that the fixation device should be flexible, but not too 
flexible, in the early stages of healing, in order to promote rapid callus formation. 
The stiffness of the fixation device should be increased after there is evidence from 
the X-Ray images that sufficient callus is formed and the cartilage calcification 
process has begun. This should promote osteochondral ossification by allowing 
better vascularisation of soft calcified tissues, as well as more rapid repair and 
remodelling of the newly formed bone. Nevertheless, it is very important to make 
sure that stiffness of the fixation device is not too rigid, because excessively rigid 
fixation has a reputation for contributing to fracture healing problems. Major 
concerns are the possible inhibition of external callus formation, maintenance of a 
fracture gap aggravated by bone end resorption, and the excessive protection of the 
healing bone from normal stresses (stress shielding) producing adverse remodelling.    
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Therefore, the specific aim for this chapter was to improve the mechanical 
environment for bone healing induced by rhBMP-2 in the femoral rat segmental 
defect model, by altering the stiffness of the fixator during the healing process. 
According to my hypothesis, healing would be accelerated by first applying a 
flexible fixator to encourage rapid cartilage formation and then imposing rigid 
fixation to promote endochondral ossification. First, it was necessary to determine a 
suitable initial fixator and a suitable time for switching from loose to stiff fixation. 
This was accomplished by a pilot histological study to determine when the 
cartilaginous callus began to mineralize.  
 
The main hypothesis for this project was to modulate the mechanical environment in 
the rat segmental defect model enhanced by rhBMP-2 treatment. For this, low 
external fixator was used at the time of surgery and 2 weeks later changed to high 
stiffness external fixator.  
 
 
 
5.2 MATERIALS AND METHODS 
 
5.2.1 In-Vivo Study Design  
 
5.2.1.1 Histological Study 
 
The first part of the study determined the degree of early callus formation produced 
in response to each fixator, and the appropriate time point at which to increase the 
stiffness of the fixator. A 5 mm, critical sized mid-femoral defect was created in the 
right hind limb of each of 27 male Sprague-Dawley rats (weight 325-360 g), treated 
with 11µg rhBMP-2 and stabilized by one of the external fixators described 
previousy ExFixLow, ExFixMed, ExFixHigh. The rats were assigned to one of 3 
groups with 3 animals per group and sacrificed 6, 9 and 14 days post surgery. In all 
groups, after the rats were euthanized femurs were harvested and fixed for histology 
in 4 % ice cold paraformaldehyde.  
 
 
Chapter Five
 
 
 119 
5.2.1.2 Healing Study 
 
Once the histological data had provided information on which fixator provided the 
best callus formation and early mineralization, as well as an appropriate time to 
change to a stiffer fixator, a full healing study was performed. For the second part of 
the experiment, a 5 mm critical sized defect was created in the right hind limb of 
each of 12 male Sprague-Dawley rats (weight 325-360 g) treated with rhBMP-2 (11 
µg) and stabilized by the ExFixLow. Two weeks after surgery all 12 rats were 
anesthetized with isoflurane (2% at 2 l/min by air mask). Before the procedure the 
rats were given one dose of analgesic buprenorphine (dose 0.08 mg/kg) 
intramuscularly in the left leg to prevent any pain or discomfort. The connection 
modules of the ExFixLow were then removed and replaced with ExFixHigh 
connective modules to increase rigidity in the healing femur for the remaining 6 
weeks of treatment; this group will be referred to as Modulated group. All rats were 
sacrificed at the end of treatment and treated femora were compared to the intact, 
contralateral femora, as well as to rats whose defects had been allowed to heal with 
continuous use of ExFixLow, ExFixMed or ExFixHigh fixators. Healing was 
monitored by weekly radiologic evaluation. Eight weeks after surgery, final X-rays 
were taken and the animals euthanized; 2 femurs were harvested and fixed for 
histology in 4 % ice cold paraformaldehyde and the remaining specimens were 
wrapped in a gauze soaked with 0.9% saline solution and frozen at -20ºC for 
physical testing. The quality of the healed defects were evaluated DXA, µCT, 
histology and biomechanical testing. All these methods were described in the 
Chapter Four, Materials and Methods Section.  
 
Animal care and experimental protocols were followed in accordance with NIH 
guidelines and approved by the Beth Israel Deaconess Medical Center Institutional 
Animal Care and Use Committee. Following a minimum 48-hour acclimatization 
period, the animals were transported to a dedicated surgical procedure room.  
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5.2.1.3 Statistical Analysis 
 
Comparisons of continuous variables between five treatment groups were performed 
using a two-tailed t-test, and by analysis of variance (One Way-ANOVA) to 
determine significant difference. 
The power level for all the data was found to be from 0.8 to 1. Thus the numbers of 
animals per group used in these studies is enough to determine a 5% difference 
between the test groups. All tests were two-tailed, with differences considered 
significant at p<0.05. Data are presented as mean±SE, unless otherwise noted. 
 
 
5.3 RESULTS 
 
5.3.1 Histological Evolution of Defects during the First 2 Weeks of Healing 
under Different Stiffness Regimens  
 
Representative micrographs of tissues within defects stabilized with ExFixLow, 
ExFixMed and ExFixHIgh at day 6, 9 and 14 are presented in Figures 5.1 and 5.2. 
The hematoxylin and eosin-stained sections (Figure 5.1) demonstrate the general 
appearance of the tissues within the segmental defect, whereas safranin O-fast green-
stained sections (Figure 5.2) show the presence of proteoglycans, which is the 
precursor to endochondral bone formation. 
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Figure 5.1 Representative longitudinal histological sections of femoral segmental defects 
after 6, 9 and 14 days of treatment with rhBMP-2 with three different stiffness fixators. 
Paraffin embedded sections stained with hematoxylin & eosin at 16x magnification. 
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Figure 5.2 Representative longitudinal histological sections of femoral segmental defects 
after 6, 9 and 14 days of treatment with rhBMP-2 with three different stiffness fixators. 
Paraffin embedded sections stained with safranin orange- fast green at 25x magnification. 
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Evaluation of the CSD in the longitudinal sections six days post-surgery showed no 
evidence of tissue formation, within the defects, which contained only the implanted 
collagen sponge no matter which stiffness external fixator was used. In the groups 
with two lower stiffness fixators, there was evidence of a periosteal reaction adjacent 
to the defect gap around the periosteum (Figure 5.3).  
 
 
 
Figure 5.3 Representative longitudinal histological sections of femoral segmental defects 
after 6 days of treatment with rhBMP-2 with lower stiffness external fixator. Paraffin 
embedded sections stained with hematoxylin & eosin. (A) Periosteum reaction with new 
woven bone formation, muscle atrophy and regeneration (shown with arrows). Also, fibrous 
connective tissue adjacent to the defect 50x magnification; (B) Hypertrophic chondrogenic 
cells, evidence of pre-osteoblastic cells and fibrous connective tissue adjacent to the defect 
at 400x magnification. 
 
Interestingly, three days later there was unmistakable deposition of new tissue in the 
defects of the two groups with the lowest stiffness external fixators. This presented 
as the formation of external callus, with the defect gap completely filled with soft 
tissue. In both groups there was marked thickening of the periosteum, which 
appeared to spread across the defect forming a bridge. This was more prominent on 
the side opposite the fixator. Bone, but not cartilage was visible in this area (Figure 
5.4).  
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Figure 5.4 Representative longitudinal histological sections of femoral segmental defect 
after 9 days of treatment with rhBMP-2 with lower stiffness external fixator. Paraffin 
embedded sections stained with hematoxylin & eosin. (A) Thickened fibrous tissue bridging 
the defect, adjacent to that new woven bone and remaining parts of collagen sponge (shown 
with arrows) at 400x magnification; (B) New bone formation around the edges of new callus 
covered with the layer of fibrous tissue. In the center of the defect collagen sponge (shown 
with arrows) 400x magnification. 
 
Furthermore, evidence of new bone formation, often around the scaffolds of the 
sponge material was seen and periosteal new bone formation on the bone adjacent to 
the defect. However and there was no real evidence of cartilage beyond a few flecks 
of safranin-O staining material in the ExFixLow group (Figure 5.2). 
 
      
Figure 5.5 Representative longitudinal histological sections of femoral segmental defects 
after 9 days of treatment with rhBMP-2 with ExFixHigh external fixator. Paraffin embedded 
sections stained with hematoxylin & eosin. (A) Fibrous and sponge material adjacent to the 
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defect at 100x magnification; (B) Fibrous and sponge material in the defect at 200x 
magnification. 
 
In contrast, in the group with the most rigid external fixator, ExFixHigh, the defect 
showed continued presence of ACS and the defect was surrounded with fibrous 
connective tissue. Although, as in the other groups there was marked woven bone 
formation along the periosteum adjacent to the defect, but the defect did not bridge 
(Figure 5.5). 
  
Two weeks post-surgery, the defects from the animals that had been treated with two 
lower stiffness fixators were filled with extensive amount of new woven bone 
around the residual sponge scaffold (Figure 5.6A&B).  
 
      
Chapter Five
 
 
 126 
Figure 5.6 Representative longitudinal histological sections of femoral segmental defects 
after 2 weeks of treatment with rhBMP-2 with ExFixMed external fixator. Paraffin 
embedded sections stained with hematoxylin & eosin (top row) and safranin orange-fast 
green (bottom row). (A) New woven bone formation and a few remaining chondrocyte cells 
in the defect at 200x magnification; (B) Thickened fibrous tissue bridging the defect and 
some areas of new woven bone at 100x magnification; (C&D) Traces of cartilage on the 
edges of callus at 50x magnification). 
 
Interestingly, in both of these groups the gap was completely bridged not by a new 
bone tissue, but by a thick band of fibrous tissue that looked like periostem. 
Surprisingly, two weeks post surgery only very small areas of cartilage was observed 
with the lower stiffness fixators (Figure 5.6C&D). The defects stabilized with 
ExFixMed group had a gap in the middle of the defect. This finding can not be 
explained at the current time and needs further investigation, but the same 
phenomenon was also observed on the µCT. 
The group with the highest stiffness external fixator had no external callus at 14 
days. Although the defect gap was filled, there was relatively little bone and most of 
the tissue appeared to be fibrous. This fibrous tissue had an appearance of thickened 
periosteum, which spanned across the defect. In addition, only very small foci of 
cartilage were also observed (Figure 5.7A&B). 
      
 
 
Figure 5.7 Representative longitudinal histological sections of femoral segmental defects 
after 14 of treatment with rhBMP-2 with ExFixHigh external fixator. Paraffin embedded 
sections stained with hematoxylin & eosin. (A) Fibrous tissue and traces and areas of new 
woven bone in the defect at 50x magnification; (B) Presence of sponge scaffold and fibrous 
tissue along the edge of the defect at 50x magnification. 
 
Chapter Five
 
 
 127 
5.3.2 Evaluation of an Improved Healing Regimen using Mechanical 
Modulation 
 
 
5.3.2.1 Radiographic Evaluation 
 
As noted in Chapter 4, weekly X-rays confirmed traces of callus formation already 
after 9 days of treatment with ExFixLow. Two weeks post-surgery the 5mm defect 
area was mostly filled with calcified tissue as shown in the x-ray image (Figure 
5.8A&B). After this was confirmed, the fixator stiffness was changed from 
ExFixLow to ExFixHigh; from now on this group will be referred to as the 
Modulated group and compared to the X-ray images from the ExFixLow, Med and 
High groups already shown in the Chapter 4. One week after the external fixator 
stiffness was changed, which was 3 weeks after the initial surgery, the x-rays 
revealed complete callus bridging with bony tissue and no evidence of radioopaque 
lines in the defect. In contrast, soft tissue persisted in those defects stabilised with 
ExFixLow and ExFixMed until 4 weeks after the surgery, and with ExFixHigh for at 
least 6 weeks post-surgery. As described later, persistence of cartilage was seen 
histologically after 8 weeks of stabilisation with ExFixHigh. 
 
Four weeks, post-surgery, i.e. two weeks after the fixator stiffness was changed to 
more rigid, the callus size of the Modulated group appeared to be at its maximum. X-
rays taken one week later revealed that the callus size started to decrease and this 
change was evident weekly until the end of 8 weeks treatment. In contrast, this 
phenomenon was not observed in the groups where the defect had been stabilized 
constantly with ExFixLow, ExFixMed or ExFixHigh. In fact, in the groups with the 
two lower stiffness fixators, the size of external callus appeared to increase as 
healing progressed until the end of treatment, whereas in the group with the most 
rigid fixator, callus size stayed unchanged (Figure 5.8A&B). 
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Figure 5.8A First set of representative radiographic images in the groups with ExFixLow, 
ExFixMed and ExFixHigh and the improved group 9 days, 2, 3, 4, 5, 6, 7 and 8 post-
surgery. In the Modulated group, ExFixLow was changed to ExFixHigh after 2 weeks. 
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Figure 5.8B Second set of representative radiographic images in the groups with ExFixLow, 
ExFixMed and ExFixHigh and the improved group 9 days, 2, 3, 4, 5, 6, 7 and 8 post-
surgery. In the Modulated group, ExFixLow was changed to ExFixHigh after 2 weeks. 
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5.3.2.2 Dual-energy X-ray absorptiometry (DXA) 
 
 
After 8 weeks of treatment bone mineral content (BMC, g), as described in the 
chapter four, was highest with ExFixLow as compared with all the other groups. 
However, there was no significant difference observed when ExFixLow was 
compared to ExFixMed and ExFixHigh, although there was a trend downward with 
the two higher stiffness fixators. Interestingly, the “Modulated” group where the 
external fixator stiffness was changed from ExFixLow to ExFixHigh 2 weeks post-
surgery, had the same BMC as the intact contralateral femur. This finding suggest 
that the group with the Modulated treatment is at a more advanced stage of bone 
healing and remodelling than the other groups. Furthermore, a statistically significant 
difference was only observed when intact contralateral femur and Modulated 
treatment was compared to all other external fixator stiffness groups as shown in 
figure 5.9 and table 5.1 and 5.3. 
 
           
         
Figure 5.9 Bone Mineral Content (BMC, g) in the segmental defect region after 8 weeks of 
treatment with rhBMP-2 was measured by DXA. Values given are means ± SEM; Asterisks 
indicate statistically significant from intact, contralateral femur, dollar signs indicate 
statistical significant difference from Modulated, and hash signs indicate significant 
difference from ExFixHigh (p < 0.05, n=9-10 per group).  
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Variable Intact Femur (n=10) 
Modulated 
(n=9) 
ExFixLow 
(n=10) 
ExFixMed 
(n=9) 
ExFixHigh 
(n=9) 
      
BMC (g) 0.075±0.01# 0.099±0.02*$ 0.091±0.02*$ 0.091±0.03*$ 0.091±0.03*$ 
      
 
Table 5.1 Bone Mineral Content (BMC, g) segmental healing characteristic of intact femur, 
Optimized, ExFixLow, ExFixMed and ExFixHigh treated with rhBMP-2 as measured by 
MicroCT (mean ± SD). Asterisks indicate statistical significance from intact, contralateral 
femur, dollar signs indicate statistical significant difference from Modulated group, and hash 
signs indicate significant difference from ExFixHigh (p < 0.05).  
 
 
5.3.2.3 Micro-computed tomography (µCT) 
 
 
The findings seen in the radiographic images were confirmed with high-resolution 
µCT data. The total cross-sectional area (TA, mm2) or callus size in the Modulated 
group was smaller when compared to the ExFixLow group and this difference was 
significant (p < 0.032). Also, a statistically significant difference was seen when the 
modulated group was compared to the Intact Femur, ExFixMed and ExFixHigh 
groups, p < 0.001 as shown in the figure 5.10 and table 5.3. 
 
            
 
Figure 5.10 MicroCT was used to measure Total area/Callus size (TA, mm²) in four 
different groups treated with rhBMP-2 (mean ± SEM) and compared to the Intact femur. 
Asterisks indicate statistical significance from intact, contralateral femur, dollar signs 
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indicate statistical significant difference from Modulated group, and hash signs indicate 
significant difference from ExFixHigh (p < 0.05, n=9-10 per group). 
 
Bone area (BA, mm2) in the defect region in the modulated group was lower than in 
the other three groups with various stiffness external fixators. However, when the 
Modulated group was compared to the intact contralateral femur the BA 19% 
increase and this difference was significant (p < 0.04), but not as big as with 
ExFixLow, ExFixMed or ExFixHigh fixators (Figure 5.11 and Table 5.3).  
 
           
 
Figure 5.11 MicroCT was used to measure Bone Area (mm²) in four different groups: 
ExFixLow, ExFixMed and ExFixHigh and the Modulated group  (mean ± SEM) and 
compared to the Intact Femur. Asterisks indicate statistical significance from intact, 
contralateral femur, dollar signs indicate statistical significant difference from Modulated 
group, and hash signs indicate significant difference from ExFixHigh (p < 0.05, n=9-10 per 
group).  
 
Surprisingly, Bone area/Total Area or Callus size (BA/TA, %) or so called bone area 
fraction in the defect region was the lowest in the Modulated treatment group as 
compared with all other groups and this difference was significant (p < 0.001, Figure 
5.12 and Table 5.3). Furthermore, when the Intact Femur group was compared to the 
Modulated group, the BA/TA%, was twice as high. 
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Figure 5.12 MicroCT was used to measure Bone Area/Total Area (%) in defects treated 
with rhBMP-2 and stabilised with various stiffness fixator and Modulated group (mean ± 
SEM) and compared to the Intact Femur. Asterisks indicate statistical significance from 
intact, contralateral femur, dollar signs indicate statistical significant difference from 
Modulated, and hash signs indicate significant difference from ExFixHigh (p < 0.05, n=9-10 
per group).  
 
 
The polar moment of inertia (pMOI, mm4) is a quantity used to predict an object’s 
ability to resist torsion. This applies to all the engineering structures including bones. 
The larger pMOI is, the less the beam will twist, when subjected to a given torque, 
although this does not include material properties which would change the outcome 
of the object’s strength.  
 
In the treatment group subjected to the Modulated stiffness, the pMOI was 2.5 fold 
higher than in the intact contralateral femur, this difference was significant, p < 
0.001 as shown in the figure 5.13. In contrast, the pMOI in the Modulated group was 
lower than the ExFixLow group, where stiffness of the external fixator was the 
lowest and this difference was significant, (p < 0.0001, Figure 5.13 and Table 5.2 
and 5.3). There was no difference observed between the two other groups with 
higher stiffness external fixators. 
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Figure 5.13 MicroCT was used to measure polar moment of inertia (pMOI, mm4) with 
various stiffness fixators and the modulated group (mean ± SEM) and compared to the Intact 
Femur. Asterisks indicate statistical significance from intact, contralateral femur, dollar 
signs indicate statistical significant difference from modulated, and hash signs indicate 
significant difference from ExFixHigh (p < 0.05, n=9-10 per group).  
 
  
The results of the physical testing are collated in Table 5.2 
 
 
 
Table 5.2 Segmental healing characteristics of Intact femur, Modulated, ExFixLow, 
ExFixMed and ExFixHigh treated with rhBMP-2 as measured by MicroCT (mean ± SEM). 
Asterisks indicate statistical significance from intact, contralateral femur, dollar signs 
indicate statistical significant difference from Modulated, and hash signs indicate significant 
difference from ExFixHigh (p < 0.05, n=9-10 per group). 
 
Variabl
es 
Intact 
Femur 
(n=10) 
ExFixLow 
(n=10) 
ExFixMed 
(n=9) 
ExFixHigh 
(n=9) 
Modulated 
(n=9) 
      
TA 
(mm²) 12.71±0.3
# $ 29.8±1.5*# $ 24.4±2.0*$ 21.5±2.1*$ 27.6±0.8*# 
BA 
(mm²) 8.27±0.2
# $ 15.8 ± 1.3*# $ 13.8 ± 1.4*$ 12.8 ± 1.2*$ 10.0±0.7*# 
BA/TA 
(%) 65.1±0.9 
$ 53.6±4.1*$ 59.6±7.6 $ 62.4±6.4 $ 36.2±2.8*# 
pMOI 
(mm4) 23.1±1.2
# $ 85.9±3.5*$# 61.8±8.2* 54.4±8.1* 61.4±3.0* 
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Representative longitudinal 2D and 3D µCT images in the Modulated treatment 
group show more advanced healing as compared to the other groups where various 
stiffness external fixators were used (Figure 5.14A&B).  
 
        
 
 
Figure 5.14A First set of representative 3D (top row) and 2D (second and third rows) 
longitudinal µCT images of femora 8 weeks post-surgery in the Modulated group and three 
different stiffness fixators. 
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Figure 5.14B Second set of representative 3D (top row) and 2D (second and third rows) 
longitudinal µCT images of femora 8 weeks post-surgery in the Modulated group and three 
different stiffness fixators. 
 
 
In the figure 5.15A&B representative 2D transverse images also confirm this 
finding. In fact, despite having the smallest amount of bone, the Modulated group, 
showed more organized structure and advanced healing in the defect after 8 weeks of 
treatment with rhBMP-2. This translated into thicker cortical bone and smaller 
amount of trabecular bone when compared to the ExFixLow, ExFixMed and 
ExFixHigh groups. Furthermore, in the Modulated group formation of new cortical 
bone had even circumference distribution of the healed callus over entire length of 
the segmental defect, which was not observed in the groups with different 
stiffnesses. The ExFixLow group had the biggest callus, but the neocortex around 
the callus was thicker and had a less symmetrical distribution than defects stabilised 
according to the conditions of the Modulated group. 
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Figure 5.15A First set of representative transverse 2D µCT images of femora 8 weeks post-
surgery in the Modulated group and three different stiffness fixators.  
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Figure 5.15B Second set of representative transverse 2D µCT images of femora 8 weeks 
post-surgery in the Modulated group and three different stiffness fixators.  
 
 
5.3.2.4 Histology 
 
Representative histological images of CSD 8 weeks post-surgery under the different 
fixator conditions are shown in the Figure 5.16. These images clearly show advanced 
CSD healing in the Modulated group as compared to the other three groups. Defects 
healed under Modulated conditions had more organization and better architecture, 
which resulted in evenly distributed neocortical continuity throughout the defect and 
smaller amount of trabecular bone in the marrow canal. This is probably due to more 
advanced remodelling process. Defects stabilised with ExFixLow, which were a 
contol to a Modulated group, also formed considerable amount of bone, but this was 
less well organized and the neocortices were less well developed. Defects stabilised 
with ExFixMed had large areas of unmineralised tissue in the central area, while 
those stabilised with ExFixHigh contained residual cartilage (Figure 5.16). 
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Figure 5.16 Representative histological sections from femoral mid-defect region 8 
weeks post-surgery and stabilized with ExFixLow, ExFixMed, ExFixHigh and in a 
Modulated group. Paraffin embedded sections stained with hematoxylin & eosin 
(two top row) and Safranin Orange (two bottom row). First and third row at 16x 
magnification and second and forth row at 25x magnification. 
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5.3.2.5 Ex-Vivo Torsion Testing 
 
The femoral defect stiffness following healing under modulated conditions was 
about significantly higher than the intact contralateral femur and in the group 
stabilised with ExFixHigh. In addition, the torsional stiffness in the Modulated group 
was 14% lower than in the ExFixLow group, however this difference was not 
statistically significant. There were no other differences observed between the 
treatment groups (Figure 5.17 and Table 5.3). 
 
 
               
 
 
Figure 5.17 Torsional stiffness of femurs treated with rhBMP-2 in four different groups 8 
weeks post-surgery, compared to the intact contralateral femur (mean ± SEM). Asterisks 
indicate statistical significance from intact, contralateral femur, dollar signs indicate 
statistical significant difference from Modulated, and hash signs indicate significant 
difference from ExFixHigh (p < 0.05, n=7-8 per group).  
 
 
Interestingly, defects healed under modulated conditions were considerable stronger 
than the intact femur and defects stabilised with ExFixLow, ExFixMed and 
ExFixHigh (Figure. 5.18 and Table 5.3). However, this only reached statistical 
significance when the Modulated group was compared to the intact femur and the 
ExFixHigh group. This is probably due to the small sample size. 
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Figure 5.18 Maximum Torque of femurs 8 weeks post-surgery compared to the intact 
contralateral femur (mean ± SEM). Asterisks indicate statistical significance from intact, 
contralateral femur, dollar signs indicate statistical significant difference from Modulated, 
and hash signs indicate significant difference from ExFixHigh (p < 0.05, n=7-8 per group).  
 
 
5.3 DISCUSSION 
 
The experiments described in this Chapter stemmed from the results discussed in 
Chapter 4 where the lower stiffness fixators accelerated the early stages of defect 
healing by stimulating the formation and mineralization of callus. By two weeks, 
there was clear evidence of mineralization, which was assumed to reflect 
endochondral ossification. Because of data from the fracture repair literature 
showing that excess motion inhibits endochondral ossification by impairing 
angiogenesis [34, 41, 88, 91, 92, 95, 106, 108, 131, 136, 155], it was decided to 
increase the stiffness of the fixator two weeks post-operatively. The results described 
in this Chapter confirm that initial stabilisation with ExFixLow followed at two 
weeks by ExFixHigh indeed improves defect healing both in terms of the speed of 
healing and the quality of the healed bone. However, histological examination of the 
defects within the first two post-operative weeks provided no evidence of an 
endochondral process. This surprising result needs further study. Nevertheless the 
data are in general agreement with several studies showing that the early stages of 
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fracture healing are especially sensitive to mechanical conditions and that these 
might direct the entire healing process [35, 83, 120, 131, 134, 142].  
 
Histological inspection revealed that six days post-surgery no healing was evident, 
regardless of the fixation. The collagen sponge used as a carrier for the rhBMP-2 
was still present in the defect and there was a slight periosteal reaction adjacent to 
the defect in the two lowest stiffness external fixator groups (Figure 5.6). By day 
nine the histological appearance of the defects changed. Defects stabilized with two 
lowest stiffness fixators had evidence of new bone formation and surprisingly the 
defect was bridged with a thickened layer of fibrous tissue that looked like 
periosteum (Figure 5.2), which was not seen in the group with rigid fixator.  Five 
days later, two weeks post surgery, the appearance of defects changed dramatically. 
Defects in the groups with lower stiffness fixators were largely filled with new 
woven bone (Figure 5.4) although the layer that bridged the defect was fibrous tissue 
with appearance of periosteum. Only small cartilaginous areas were present, 
consistent with the formation of bone through an endochondral process. However, 
this must have happened very quickly, within a period of 5 days. An alternative 
explanation is that the bone formed by direct osteogenesis, without a cartilaginous 
intermediate. Further experiments are needed to distinguish between these two 
possibilities. Remarkably, defects stabilised with the most rigid fixator, lacked 
external callus, and showed no evidence of ossification. Small areas of cartilage were 
visible and ACS was still present (Figure 5.5).  
 
The histological data confirm the radiologic data of Chapter 4 in demonstrating that 
healing of the defects is favoured by the lowest stiffness fixator. However, contrary 
to expectation, no cartilaginous callus was seen at any time point. At 9 days the 
defects stabilised by ExFixLow contained fibrous tissue, and at 2 weeks they were 
mostly filled with new bone. As noted, the biological changes that occur during the 
interim 5 days merit further scrutiny. There are almost no prior published data to aid 
consideration of this point. Yasko et al. [61] showed that, under the conditions 
imposed by their fixators, healing of rat segmental defects occurred via an 
endochondral process. The purpose for their study was to determine whether 
implants of rhBMP-2 cause bone formation in an osseous bone location and whether 
the activity of this protein promotes functional angiogenesis at the site of 
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implantation, and whether a segmental defect created at the length that predictably 
precludes union, can be healed by the bone that is formed. They used two different 
doses 1.4 or 11 µg of rhBMP-2 protein implanted in each defect together with 
guanidine-hydrochloride extracted demineralized rat bone matrix as a carrier and 
compared this to the matrix carrier only. They found that both doses of rhBMP-2 
induced formation of endochondral bone in the osseous defect, in a dose dependent 
manner. The high dose yielded significant bone formation resulting in radiographic, 
histological and mechanical evidence of union. On the contrary, lower dose of 
protein failed to show any new bone formation until the third or forth week and the 
scant bone that formed in the defect failed to progress resulting in a non-union in all 
instances. Most importantly they found that no specimen had formation of bone in 
the defect without evidence of formation of cartilage as observed by a time course 
histological study. They also found that implantation of rhBMP-2 did not exhibit 
enhanced functional blood flow in the defect seven days post surgery. Even though, 
determining the mechanical environment was not one of the aims of this study, they 
also observed that in several specimens bone formed eccentrically along the region 
opposite the plate. They postulate that the ultimate shape and size of the resultant 
bone that formed in the defect may have followed the pattern related to the 
mechanical environment of fixation device they used.  
 
The premise for the change to a much stiffer fixator at 2 weeks (fixator 
“Modulation”) was to potentiate the more rapid calcification of a cartilaginous 
callus, which would then be replacted by a woven bone and then remodelled into 
lamellar bone. Although this premise was shown to be incorrect, it nevertheless 
produced a dramatically beneficial effect on defect healing. Radiographic images 
revealed that one week after modulation there was complete osseous union with no 
evidence of soft tissue, unlike in the other groups. Furthermore, as healing 
progressed weekly X-rays showed decrease in the external callus and at the end of 
eight weeks treatment the callus size appeared to be smaller and resembled the shape 
of the native femur (Figure 5.8A&B). These findings were supported by 3D high-
resolution µCT images (Figure 5.14A&B and 5.15A&B), where the decrease in the 
external callus was found to be significantly smaller than in defects where the 
ExFixLow had not been exchanged for a high stiffness fixator Interestingly, the bone 
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area of the healed defect was also significantly lower. In fact, in the Modulated 
group, the bone area was significantly lower than in any other stiffness group, but it 
had more bone than the intact, contralateral femur. In addition, transverse images 
from the healed defects in the Modulated group appeared to have a more uniform 
and symmetrical distribution of circumferential callus and smaller numbers of 
trabeculae, than in the other treatment groups.  Transverse µCT revealed that 
formation of a new cortex was especially well developed in the Modulated group 
(Figure 5.15A&B). This conclusion is supported by the histological data showing 
thicker and uniform distribution of neocortical callus (Figure 5.16).  
 
The marrow cavity of defects healed under Modulated conditions contained far 
fewer trabecular struts than those of the other groups, further suggesting enhanced 
osseous remodelling and maturation. Defects stabilised with lowest stiffness fixator 
for the entire 8 weeks of the experiment had a bigger external callus, thinner and 
asymmetric distribution of neocortical bone, and much higher amounts of trabecular 
bone inside the marrow cavity. In the two higher stiffness groups the repair process 
appeared to be even slower. Histological slides stained with safranin O-fast green 
revealed the presence of residual cartilage within the defect area (Figure 5.15 third 
and forth row). This may imply that, in these two groups, the healing process after 
eight weeks is incomplete. 
 
The radiographic, µCT and histologic findings were further supported by additional 
analyses. For example, BMC, as measured by DXA, returned to the untreated 
contralateral femur values within the eight weeks after Modulation treatment. On the 
contrary, in all other groups where different stiffness external fixators were used, 
BMC remained significantly higher than normal at 8 weeks. This might suggest 
slower remodelling, associated with the accumulation of more mineralized tissue, 
which would make bones more brittle and could jeopardize the mechanical integrity 
of repaired defect. This conclusion is supported by the results of biomechanical 
testing, which showed that torsional stiffness in these groups were significantly 
lower than in the Modulated and lowest stiffness fixator groups, but reached the 
same values as the contralateral femur. Interestingly, the maximum torque, which is 
the amount of force needed to break the bone in torsion, was significantly higher 
than contralateral femur in all groups, except ExFixHigh group. The higher 
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maximum torque in the Modulated group might have been attributed to the more 
advanced healing of the CSD defect. This finding is reflected by smaller callus, the 
formation of which appeared to be accelerated, and enhanced remodelling resulting 
in a more rapid reduction of periosteal and endosteal callus, especially when 
compared to the group with lowest stiffness external fixator. The enhanced repair 
and remodelling of the Modulated group is also reflected in a higher strength and 
lower bone mineral content. These effects might have been caused by smaller IFM in 
the defect, although this was not measured in this study, which might have prevented 
disruption of vascular supply, hence allowed faster repair process and increased 
remodelling of the repaired defects. Furthermore, the effect of natural weight bearing 
on defect healing was not investigated in this study and needs to be addressed in the 
future experiments. 
 
In conclusion, this current experiment revealed that early axial modulation, from 
lower to more rigid fixation, resulted in accelerated callus maturation, which 
presented with more organized bone architecture of healed defects. In addition, the 
Modulated group appeared to induce faster remodelling of endosteal and periosteal 
callus tissue, which exhibited with reduced callus size at the end of treatment as 
compared with the Low external fixator group. Moreover, the torsional strength of 
the 5mm healed defect was significantly increased. These factors could be also 
associated with a secondary effect of early weight bearing related to decreased pain 
in the injured femur due to a more stable defect gap conditions with more rigid 
fixator, which allowed healing of defect in more efficient and timely manner. 
Surprisingly, we were not able to obtain strong histological evidence of 
endochondral ossification as a mechanism of defect repair. Further investigation is 
needed to determine the pathway of bone healing in CSDs and how this is modulated 
by the ambient mechanical environment.  
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Summary of in-vivo and in-vitro results of the physical testing are collated in Table 
5.3 
 
 
Table 5.3 In-vivo segmental healing characteristics of Intact femur, Modulated, ExFixLow, 
ExFixMed and ExFixHigh treated with rhBMP-2 as measured by MicroCT (n=9-10), DXA 
(n=9-10), Torsional testing (n=7-8), (mean ± SEM); and in-vitro results from axial 
compression cunstruct testing: no defect, 5mm empty defect and with different inserts such 
as rubber, LDPE, wood (mean ± SEM, n=6). Asterisks indicate statistical significance from 
intact, contralateral femur, dollar signs indicate statistical significant difference from 
Modulated, and hash signs indicate significant difference from ExFixHigh (p < 0.05). 
Variables 
Intact 
Femur 
(n=10) 
ExFixLow 
(n=10) 
ExFixMed 
(n=9) 
ExFixHigh 
(n=9) 
Modulated 
(n=9) 
 In-Vivo Data 
TA 
(mm²) 12.7±0.3
# $ 29.8±1.5*# $ 24.4±2.0*$ 21.5±2.1*$ 27.6±0.8*# 
BA 
(mm²) 8.3±0.2
# $ 15.8 ± 1.3*# $ 13.8 ± 1.4*$ 12.8 ± 1.2*$ 10.0±0.7*# 
BA/TA 
(%) 65.1±0.9 
$ 53.6±4.1*$ 59.6±7.6 $ 62.4±6.4 $ 36.2±2.8*# 
pMOI 
(mm4) 23.1±1.2
# $ 85.9±3.5*$# 61.8±8.2* 54.4±8.1* 61.4±3.0* 
BMC (g) 0.08±0.01# 0.1±0.02*$ 0.09±0.02*$ 0.09±0.03*$ 0.1±0.02*$ 
Torsion 
Stiffness 
(N/mm) 
n=9 
37.3±1.7 
 
 
n=7 
52.2±4.4 
 
n=8 
42.7±2.8 
n=7 
39.7±4.0 
n=8 
45.6±2.9 
Max 
Torque 
(N*mm/ 
degree) 
255.1±16 
 
275.9±11 
 
261.7±24 244.9±14 309.8±26 
Stiffness 
(N/mm) In- Vitro Data – Axial Compression Construct Testing (n=6) 
No 
Defect N/A 33.6±0.9
$ 36.0±0.9$# 39.6±0.6# N/A 
5mm 
Defect N/A 33.6±0.9
$ 36.0±0.9$# 39.6±0.6# N/A 
Rubber N/A 38.7±0.7$ 42.7±0.5$# 46.2±0.8# N/A 
LDPE N/A 214.8±9.6 220.0±6.8 263.2±9.5 N/A 
Wood N/A 315.9±36# 351.4±24# 368.2±21 N/A 
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The overall aims of this project were to determine whether the healing of CSDs in 
response to rhBMP-2 is responsive to the ambient mechanical environment and, if 
so, whether this information could be used to improve healing. Although the effects 
of mechanics on the spontaneous repair of sub-critical sized, osseous defects have 
been studied extensively, there is almost no prior literature concerning CSDs. 
Moreover, the intersection of mechanical signals and biological signals in the context 
of bone healing in-vivo has not been studied in detail. Thus, the novelty of this study 
is that it is the first to demonstrate interactions between the mechanical environment 
and the ability of a locally applied growth factor to enhance CSD healing in-vivo.  
 
In many cell types the mechanical environment critically influences cellular 
behaviour [156-159]. Several studies using different cell types found that BMPs and 
their antagonists are regulated by mechanical stimulation and influence BMP 
signalling in an autocrine or paracrine fashion [160-163]. Furthermore, responses of 
endogeneous and exogenous BMPs to mechanical stimulation have been 
demonstrated in several studies, and it has been reported that there is optimal 
magnitude and type of loading for BMP-2 expression [75, 76, 145]. In one in-vitro 
study,, for example, static tensile force enhanced the osteoblastic differentiation of 
MSCs in response to BMP-2, while tensile force alone increased cell proliferation 
[76]. In light of studies such as these, it is not surprising that my data demonstrate 
such a powerful effect of the mechanical environment on the healing of CSDs in 
response to BMP-2.  
 
The data presented in this thesis confirm the high responsiveness of CSD healing to 
mechanical influences, but suggest that there are important differences between the 
responses of CSDs and sub-critical sized defects. Importantly, it proved possible to 
enhance dramatically the healing of CSDs in the rat femur by modulating the 
stiffness of fixation during the healing process. If also true for humans, this could 
have important clinical implications. 
 
Investigation of these issues required the design and manufacture of novel fixators of 
known stiffness, and whose stiffness could be reliably modulated in a precise, 
quantitative fashion at will. As described in Chapter 2, the newly developed external 
fixator has several unique features. Firstly, unlike alternatives found in the literature 
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[77, 164], including one I have used in the past (ExFixOld) [54, 55, 60], the new 
fixator was designed to have a minimal mass to avoid uncontrolled motion due to 
inertia. In addition, to create a reproducible 5mm defect with the minimal trauma to 
the bone and surrounding soft tissue, conventional and rotating saws were not 
considered. Instead a saw guide was created and used in conjunction with a gigly 
(wire) saw. Connecting elements of various stiffnesses were created for the external 
fixator to produce different mechanical environments. This configuration also allows 
the connecting elements to be changed in-vivo while still attached to the animal, 
thereby allowing the mechanical environment to be changed during the healing 
process. This is important, because it is likely that different stages of healing respond 
differently to mechanical stimuli. In many of the experiments described in this 
thesis, the novel fixator was compared to an earlier model, ExFixOld, with which 
our laboratory has much experience and a wealth of historical data. 
 
Only three different connective elements were created for this project, allowing 
study of three different stiffnesses, but additional stiffnesses could be created easily 
depending on the requirements of future studies. Furthermore, the fixator was made 
so that a preset offset of exactly 6mm was reproducibly and reliably achieved using 
precisely manufactured titanium screws designed specifically for this fixator. This is 
in contrast to the majority of previously published fixators, including ExFixOld, 
where investigators have used K-wires to secure the fixators [54-56, 59-61, 165]. 
Descriptions of previous devices, moreover, do not mention the preset offset from 
the bone surface to the plate or external fixator, which makes it difficult to determine 
the local mechanical conditions. In addition, K-wires are known to have poor 
rotational stability, and the type of motion this creates has been shown to inhibit the 
process of bone healing, especially when it is used as an intramedullary nail [97]. 
Knowing the precise local mechanical conditions is essential to the interpretation of 
the outcome of bone healing studies.  
 
These observations raise another important issue -- fixator stability. Although 
mechanical properties can be easily determined experimentally, surprisingly few 
investigators have characterized the in-vitro and in-vivo mechanical properties of the 
fixation devices used for their studies. The most important mechanical factors are the 
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axial and shear IFMs in the plane of the fracture surface. These movements are 
influenced by the load applied to the fixation device (weight bearing and muscle 
forces) and the stiffness of the device. Although, due to limited resources, we were 
not able to perform torsional stiffness testing, the axial test is sufficient enough to 
answer the key question proposed in this thesis. The mechanical properties of the 
newly designed external fixators were examined at three levels. First, in-vitro three 
point bending tests were carried out to determine the rigidity of the stability bars.  
Fixators were then installed on excised rat femurs, with and without 5mm defects, 
and tested in axial compression to imitate weight bearing. Finally, to approximate the 
alterations in the mechanical properties of the defect as it heals, rubber, plastic and 
wood were inserted into the defects to simulate different phases of healing. The 
results of these studies showed convincingly that the mechanical environment cannot 
be explained solely in terms of the properties of the components used to construct 
the fixator. It is essential to measure the overall mechanical properties of the entire 
fixator construct attached to bone, and to take into account mechanical contributions 
from the defect tissue itself as it heals. These issues were most dramatically 
illustrated with ExFixOld, which has an extremely stiff stability bar, yet provided 
minimal support to a fresh defect because of its offset (distance) from the bone and 
because it was secured with K-wires. However, according to my mechanical testing 
simulation data, as healing progressed and contributed increasingly to the overall 
stability of the defect, femora stabilised with ExFixOld became extremely stiff. This 
further indicates the need to appreciate temporal changes in the mechanical 
environment that occur as healing progresses. Besides the parameters tested in this 
study, which determine the in-vitro stability of the fixation, other factors are 
important for in-vivo success. To prevent a screw from pulling out from the bone, a 
certain depth of thread (core diameter) and thickness between the threads were 
chosen specifically for the cortical bone material. Also, the ratio of drill diameter to 
the screw diameter, that determines the pre-stress in bone due to insertion of the 
threaded pins, was also carefully calculated to prevent bone fractures through the 
pinholes. The possible contribution of surrounding soft tissues to the mechanical 
environment within the defect was not considered in my studies, although this should 
be investigated in the future. Having constructed and characterised the novel 
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fixators, their effects on the healing of a 5mm femoral defect in the rat were 
investigated. 
  
The in-vivo studies showed that earlier and bigger callus was formed with the lower 
stiffness external fixators. On the contrary the more rigid device produced 
significantly smaller callus, with delayed appearance of external callus over the same 
time period. Nevertheless, all defects healed and after 8 weeks the material 
properties (bone mineral content, g) of the new bone formed with the different 
stiffness fixators were not significantly different.  However, the structure of the 
healed defect, as assessed by µCT and histology, differed considerably. With the 
highest stiffness fixator, ExFixHigh, the new bone was irregular in morphology and 
contained discontinuities, which appear histologically as areas of cartilage. Such 
discontinuities were less evident using the fixator of medium stiffness, ExFixMed, 
but the transverse µCT images suggested in each case a “hole” in the centre of the 
healed bone. Histology did not reveal extensive areas of cartilage in this region, so 
they are best explained as areas of unmineralised fibrous tissue. Surprisingly, the 
most impressive healing was accomplished with the lowest stiffness fixator, 
ExFixLow: defects were filled with bone, no cartilage was seen and the neo-cortex 
was regular and continuous. This result was unexpected, because data from studies 
of sub-critical defects and fractures suggest that low stiffness generates abundant 
cartilage that fails to undergo endochondral ossification because excessive IFM 
disrupts the formation of new blood vessels. This indicates that the mechano-biology 
of the healing of CSDs is either dissimilar from that of fractures or sub-critical sized 
defects, or that stiffness needs to be further reduced before it becomes detrimental to 
the healing process.  
 
Based upon these data, it was decided to attempt to improve outcome by modulating 
the stiffness of the fixator during healing. The original hypothesis, consistent with 
the radiological data shown in Chapter 4, was that low stiffness accelerated healing 
during the first two weeks, at which time mineralization was first evident. At the 
time, we considered this to be the beginning of endochondral ossification, a process 
thought to be favoured by high stiffness. Accordingly, two weeks post-surgery the 
connection elements of the fixator stability bar were changed from lowest to highest 
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stiffness. The results of this experiment, described in Chapter 5, are quite 
provocative. 
 
As hypothesised, healing was dramatically enhanced by modulating the stiffness 
during healing, in the manner described above. Compared to defects stabilised with 
an invariable stiffness fixator for the entire 8 weeks, healing was accelerated and the 
newly formed bone had far more uniform new cortices and fewer trabeculae within 
the marrow cavity; no cartilage was present. The external callus was significantly 
smaller in the Modulated group as compared to the ExFixLow group, but 
significantly higher than in all other stiffness groups including the contralateral 
femur. In contrast, the amount of bone within the callus was significantly lower in 
the Modulated group than in all different stiffness experimental groups. Indeed, the 
amount of bone within the callus was only 19% above the bone content of the 
contralateral femur. In addition, the stiffness of the healed defects in the Modulated 
group was significantly different from that of the intact femur and ExFixHigh, and 
the healed defects of the Modulated group were markedly stronger than all other 
tested groups. Furthermore, the bone mineral content of the healed defect, as 
determined by DXA, in the Modulated group were significantly lower than in all 
other stiffness groups, but were the same as the contralateral femur. Hence, this 
observation might suggest a more advanced healing and remodelling process in this 
group. Translated into a clinical setting, such an effect might allow weight bearing at 
a far earlier time than is presently the case. 
 
Histological examination of defects at 6, 9 and 14 days gave surprising results. 
Based upon the supposition that healing would proceed via an endochondral process 
and that the first signs of radioopacity would indicate the beginning of cartilage 
mineralization, we expected to see cartilage at days 9 and 14. Instead, there was very 
little cartilage in any of the specimens. Instead, defects stabilised under low and 
moderate fixation had little evidence of new bone formation in the defect 9 days post 
surgery, yet extensive areas of woven bone after 14 days of treatment. In contrast, 
those stabilised under high stiffness had only fibrous tissue. Surprisingly, at days 9 
and 14 in the two lowest stiffness groups, the defects were bridged by the thickened 
layer of what appeared histologically to be periosteal fibrous tissue. However  from 
the X-ray images, this region appeared either as calcified cartilage or newly 
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mineralized bone. Further research, including the examination of undecalcified tissue 
sections, is needed to resolve this issue. 
 
The formation of bone at low and medium stiffness appeared to have been rapid. At 
6 days there was almost no evidence of repair activity. The defects were acellular 
and filled only with the collagen sponge used to deliver the rhBMP-2, although at the 
lowest two stiffnesses there was evidence of a marked periosteal reaction adjacent to 
the defects. At 9 days, however, there was extensive ingrowth of fibrous tissue into 
the defects, which at the lowest two stiffnesses had become woven bone by day 14. 
The absence of cartilage is puzzling and forces us to consider the possibility that 
healing occurred by the direct differentiation of precursor cells into osteoblasts rather 
than by endochondral ossification. If this were so, its apparent enhancement by low 
stiffness is highly surprising. Clearly, more research into the mechano-biology of 
healing under these conditions is warranted.  
 
Relevant to our data is a recent report of a study by Claes et al. [149] where the 
investigators “dynamized” a rat osteotomy one week post-surgery, having first 
stabilised the defect with a high stiffness fixator. In their experiments switching from 
stiff to flexible fixation did not improve healing of the defect. This is compatible 
with research by other investigators [98, 166] showing that when fixation stability 
was changed from rigid to more flexible as healing progressed, there was no 
significant improvement in the biomechanical properties of the bone at the end of 
study. In some cases, it was even detrimental, no matter whether early or late 
dynamization was applied. Similarly, axial passive and active dynamisation under 
external fixation in stable and unstable fracture types seemed to provide an increased 
amount, and a more uniform distribution of, periosteal callus. However, changing 
fixator stiffness by removal of excessive pins or connecting sidebars did not enhance 
bone fracture healing. In contrast, only one study in dogs by Larrson et al. [151] 
found that early dynamisation appeared to accelerate callus maturation, as reflected 
by higher periosteal new bone formation and greater torsional stiffness. Importantly, 
weight bearing, without exception, proved to be the most important stimulus in 
restoring fractured bone to its original mechanical strength [167]. 
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As noted, nearly all the literature on bone healing comes from studies of fractures 
and sub-critical sized defects. A major difference between these settings and the 
CSDs studied here is the ready availability of periosteal cells in fractures and sub-
critical defects. This may be the crucial difference between sub-critical size and 
critical size defects that explains their different abilities to heal. Recent 
transplantation studies by the O’Keefe group [168-171] have confirmed the 
importance of the periosteum to the healing of fractures. By undertaking segmental 
cortical graft transplantations between wild-type and ROSA mice., where all cells 
are LacZ+, these investigators were able to distinguish host cells from donor cells. 
Zhang et al. [171] used this model to show the essential role of periosteal progenitor 
cell in bone graft healing. They noted that the surrounding periosteum is the first 
tissue to respond to injury. It undergoes a large proliferative response and cells from 
the cambial layer differentiate into chondrocytes to form a cartilaginous soft callus 
that subsequently undergoes endochondral ossification. They found that 
approximately 70% of osteogenesis on the graft was attributed to the expansion and 
differentiation of donor periosteal progenitor cells. Furthermore, engraftment of 
BMP-2 producing bone marrow stromal cells on nonvital allografts showed marked 
increases in cortical graft incorporation and neovascularization. 
 
The above mechanism of periosteally initiated healing is not available to a CSD. Of 
possible high significance, our histological observations suggest that, in our model, 
periosteal cells spread along the surface of the collagen sponge, eventually forming a 
continuous bridge. This may be in response to a BMP-2 chemotactic gradient formed 
as BMP-2 leaches from the sponge. The study of Zhang et al. [171] and the present 
study both suggest that direct activation of the local periosteal progenitor cells is 
necessary to induce an early healing response. Intriguingly, this migration of 
periosteal cells in our models appears to occur first on the side furthest away from 
the fixator, which is also the side where radio-opacity is first noted. Periosteum is 
known to contain multipotent progenitor cells, and it is tempting to speculate that, 
under the mechanical conditions created by the external fixators, these cells undergo 
osteoblastic differentiation within the defect. Interestingly, an in-vitro study by 
Mitsui et al. [145] investigated BMP expression in cultured osteoblastic cells 
subjected to mechanical compression force. They used 0.5, 1, 2 and 3 g/cm2 
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compressive force on the cells and found that the highest BMP expression was seen 
when they used 1g/cm2 force. This was associated with decreased expression of 
BMP antagonist such as chordin, noggin, and gremlin. This study identified an 
optimal force magnitude for supporting a BMP response, and demonstrates one way 
in which external fixator stiffness could help determine responses to BMP and 
induced osteogenesis. 
 
The only other published report on the biology of CSD healing in response to 
rhBMP-2 is that of Yasko et al. [61]. Using a rat model similar to ours, stabilized 
with high-density polyethylene plate fixed with four K-wires, they demonstrated that 
healing occurred via a classical endochondral mechanism. The difference between 
our findings and theirs presumably resides with the different mechanical 
environments generated by the different fixation devices used in the two studies. 
Healing through endochondral ossification in the studies of Yasko et al could be also 
related to a different carrier [61]. They used demineralized rat-bone matrix (DBM) to 
delivery rhBMP-2. Although not able to induce bone healing by itself, DMB may 
nevertheless have provided additional growth factors that contributed to a 
chondrogenic response during the early the healing process.  
 
Collectively, my data and those in the literature indicate the importance of 
mechanical forces in determining cell fate, as first suggested by Roux [37] and later 
in experimental data by Pauwels [36]. These hypotheses are consistent with data 
from multiple studies in fracture healing which showed that the mechanical strength, 
stiffness and the size of the fracture callus is related to the degree of fixation stability 
[81, 88, 133, 143]. Moreover, it has been observed that certain loading conditions 
inhibit the process of healing, both in animal models and clinically. For instance, 
monitoring of patients has demonstrated that the fixation systems in clinical use 
create complex load situations resulting in a mixture of different movements such as 
axial compression, translational shear, bending and axial torsion [87, 117, 172]. It is 
therefore essential to define boundaries of fixation stability for optimal healing on 
the basis of both clinically relevant fixation and loading conditions.  
 
My data strongly suggest that healing of CSDs does not follow the rules established 
for fractures and sub-critical sized defects, and needs to be experimentally 
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investigated in its own right. In further agreement with this, histological data suggest 
that healing of CSDs does not occur by forming a double cortex [54-56, 59-61, 173], 
as is the case with rodent fracture healing [174-178]. 
 
The major conclusion from my work, that the healing of CSDs in response to BMPs, 
is exquisitely sensitive to the ambient mechanical environment, which can be 
manipulated to accelerate and improve repair, harks back to the pioneering studies of 
Roux over 100 years ago. Roux [37] was one of the first scientists to perform 
laboratory experiments, measuring strain transfer in bone models with 
photoelasticity equipment. He compared the mechanical environment on cells in a 
fracture callus with fracture repair patterns, and he proposed that deformation of 
shape is the specific stimulus for the formation of collagenous fibrils and hydrostatic 
compression is the specific stimulus for the formation of cartilaginous tissue; for 
osteogenesis to occur would require that the mechanical environment first becomes 
stabilized by the presence of fibrous tissue. Since the time of Roux, Pauwels and 
many other scientist, the mechanical conditions of bone repair have been widely 
studied by many scientists and clinicians, but many fundamental issues concerning 
the relationship between the mechanical environment and cellular response remain 
unclear, especially when the fracture gap is too large to heal spontaneously. While 
there exists an extensive literature, involving both clinical and experimental animal 
studies, reporting the effects on fracture repair of the local mechanical environment 
using various fixation devices with and without biologic therapies [35, 38, 41, 66, 
73, 81, 83, 84, 87, 88, 91, 92, 98, 117, 120, 134-136, 138, 142, 143, 151, 164, 166, 
172, 179-181], there are none concerning the healing of CSDs. This might be related 
to the false assumption that CSD healing is governed by the same rules as those that 
govern the healing of different types of fractures and osteotomies. 
 
In Conclusion, this study clearly shows that critical size segmental defects treated 
with rhBMP-2 heal differently from fractures and this should be taken into 
consideration not only when planning new experimental studies but also when 
developing strategies for improving the clinical outcome. Careful selection of not 
only the biologic treatment but also the type of fixation device is required. More 
studies are required to establish the mechanisms through which biology and 
biomechanics interact at the tissue and cellular level. Once these are adequately 
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understood and translated into clinical practice, it will be possible to heal bones more 
quickly, inexpensively and reliably than is presently the case. 
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FUTURE WORK 
 
Several of the research areas touched upon in this study would benefit from further 
investigation. Because only 3 different stiffnesses and one modulation were 
compared in this study, we do not know whether healing could be enhanced further 
by using a greater range of stiffnesses, or by different modulation patterns. It would 
be a straightforward matter to produce fixators with a greater range of stiffnesses and 
to perform the necessary experiments.  
 
A fully optimized repair protocol might reduce the need for rhBMP-2. Because 
rhBMP-2 is so costly, any reduction in its consumption would be of great socio-
economic benefit. As noted, extremely large, wildly supra-physiological doses of 
rhBMP-2 are presently used. A protocol in which the mechanical environment is 
optimized could well reduce the rhBMP-2 requirement by log orders of magnitude. 
 
A third fruitful area of further investigation is to understand the mechano-biology of 
healing under the conditions described in this thesis. The histological data are 
tantalising and provide evidence that healing under the conditions tested in this 
project may not follow the classical route of endochondral ossification. Clearly, there 
is much that could be done to study this. At a minimum, precise histological and 
imaging studies are needed to monitor, in a detailed fashion, the formation of bone 
within the defects. In-vivo µCT and other sophisticated in-vivo imaging techniques 
would be very helpful here. Coupled to such studies is the need to determine the 
origin of the osteoprogenitors that ultimately differentiate into bone within the 
defect. Preliminary histological data point to the periosteum as an important source, 
but bone marrow, adjacent muscle and circulating osteoprogenitors are additional 
possibilities that need evaluation.   
 
Finally, because the ultimate goal of all experimental investigations of this type is to 
improve clinical outcome, conditions that have been optimised in the rat model need 
to be evaluated in a large animal, such as the sheep. Any reasonable procedures that 
allow CSDs to heal quicker and better, and which permit earlier weight bearing, 
while eliminating the need for bone grafting and, perhaps, reducing the need for 
rhBMP-2, should form the basis of future clinical trials. 
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Abstract 
 
Influence of the Mechanical Environment upon the Healing of Segmental Bone 
Defects: Evaluation in a Rat Femoral Model 
 
Despite the intrinsic ability of bone to heal, there are numerous clinical 
circumstances where bone healing is defective. My research focuses on the loss of 
large segments of bone after traumatic injury. If these defects are too large, they will 
not heal spontaneously. Surgical approaches to healing such defects can be 
supplemented with recombinant, human bone morphogenetic proteins -2 and -7 
(BMP-2 and BMP-7). Despite this, the clinical management of critical-sized defects 
remains problematic. Our project is based on the hypothesis that the healing of 
critical-sized defects in response to BMP-2 can be dramatically improved by 
manipulating the mechanical environment within the defect. To study this, we have 
developed custom external fixators, which allow the mechanical environment of a 
segmental defect in the rat femur to be manipulated experimentally in vivo. 
Experiments are in progress to determine the effect of fixator stiffness on the healing 
of these defects in response to BMP-2. The early results show a large difference in 
callus size depending on the stiffness of the fixator. 
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Abstract 
 
Influence of the Mechanical Environment upon the Healing of Segmental Bone Defects in a Rat 
Model Studied with a Novel, Customized, External fixator 
 
1V. Glatt, 2R. Matthys, 1A.Ivkovic, 1C. Evans 
1Department of Orthopaedic Surgery, Harvard Medical School, Boston, MA, US, 
2AO Development Institute, Davos Platz, Switzeerland  
 
Introduction: Despite the intrinsic ability of bone to heal, there are still numerous clinical circumstances where bone healing is 
defective and demands the attention of the physician. Common examples include the delayed and non-union of fractures, and 
the loss of large segments of bone after traumatic injury, tumor resection and failed arthroplasty. There are several surgical 
approaches to enhance the healing of human bones, and these have been supplemented in recent years by the introduction of 
recombinant, human bone morphogenetic proteins -2 and -7 (BMP-2 and BMP-7) into clinical practice in combination with 
different fixation devices. Over the years there have been many advances in technology, which helped to improve the fixation 
for critical sized defects. Despite these improvements, the clinical management of critical-sized defects remains problematic for 
surgeons today because it isn’t clear how stiff or flexible the fixation device should be to optimize bone healing. Our project is 
based on the hypothesis that the healing of critical-sized defects in response to BMP-2 can be dramatically improved by 
manipulating the mechanical environment within the defect. Accordingly, this project aims to investigate the influence of the 
mechanical environment on bone healing in response to BMP-2 in a rat, critical-sized defect model. The mechanical 
environment of the defect is altered with a custom made external fixator whose stiffness can be changed in a reliable, 
quantitative fashion.  
Materials and Methods: Novel, second generation, external fixators that can be adjusted to provide three different stiffnesses 
were designed specifically for the rat femur. All materials in the fixator were chosen to be the same as used clinically for 
human implants. The screws for a new external fixator are made out of titanium (Ti). The stability bars are made out of 
polyetheretherketones (PEEK). The diameter of the screws is 1mm and the length is 12.75mm. The distance between the 
screws is 4mm and the distance between the middle screws is 11mm. All holes are predrilled using a 0.79mm drill bit. The 
screws are locked in the corresponding holes of the fixator, which is parallel to bone surface and set at the distance of 5mm. 
The fixator stiffness can be changed by changing the stability bars to provide stiffnesses of 40, 70 or 100%, as required. To 
create reproducible 5mm defects in all rats the guide was designed for a 0.22mm wire saw that clips on the external fixator in 
between the two middle screws. A rat, femoral, critical-sized defect model was used to test this fixator in-vivo. A 5mm defect 
was created in 6 Sprague-Dawley rats and treated with rhBMP-2 applied on a collagen sponge with external fixators providing 
40, 70, 100% stiffness. Animals were x-rayed weekly for 8 weeks to monitor bone healing. 
Results: A second generation external fixator prototype was successfully created and manufactured for testing in-vivo (Figure 
1). An in-vivo pilot study showed that the there is a difference in bone healing depending on external fixator stiffness. Weekly 
x-rays revealed that bone callus size was biggest in the group with the lowest stiffness (40%) fixator. Furthermore, early callus 
formation was seen in this group and 70% stiffness group after 9 days of treatment. However, the group with 100% stiffness 
external fixator had no callus formation after 9 days of treatment. In this group callus formation was delayed until after two 
weeks of treatment. By the third week defects were bridged with all fixation methods with the biggest callus in 40 and 70% 
stiffness fixators and smaller callus with 100% stiffness (Figure 2).  
Discussion: Loss of large segments of bone leads to critical-sized defects that fail to heal spontaneously. Although healing can 
be induced by recombinant, human bone morphogenetic protein-2 (rhBMP-2), the clinical response is modest. The current 
project focuses on the influence of the mechanical environment on the healing of critical sized segmental defects in response to 
rhBMP-2. In preliminary studies, using a first generation external fixator to stabilize the defect, we have been able to achieve 
osseous union using rhBMP2 and BMP-2 gene transfer with an adenovirus vector. However the rate of healing and the 
mechanical properties of the healed bone are inconsistent. We hypothesized that this is due to insufficiencies in the rigid 
external fixator, which generates an unfavorable local mechanical environment. Therefore, we have designed a new, second 
generation external fixator which allows us to control and measure with precision, the mechanical environment within the 
critical-sized segmental defect in-vivo. Our pilot study shows that fixator stiffness is important in the biologic process of 
healing bone. In fact, from the weekly x-rays we observed that with 40 and 70% stiffness fixator callus formation was seen 
already after 9 days of treatment, whereas defects subjected to 100% stiffness had no callus. Furthermore, after two weeks bone 
regeneration was seen in all groups, but two lower stiffness groups had bigger callus formation as compared to the stiffest 
fixator. This confirms findings in the literature that if there is too much micro motion during healing, bone bigger callus forms 
(1) Material, structural and mechanical testing will be performed to determine how important early callus formation and size is 
to the physical properties of the healed bone. We will apply this knowledge to manipulate fixator stiffness through the course of 
healing to get rapid bone regeneration and best quality of healed bone. The findings from this study will be highly relevant to 
the surgical management of patients with segmental bone defects and, possibly, delayed and non-union fractures.  
 
 
               Reference: 1. Gomez-Benito MJ, Garcia-Aznar JM, Kuiper JH, Doblare M 2006 A 3D computational simulation of fracture 
callus formation: influence of the stiffness of the external fixator. J Biomech Eng 128(3):290-9. 
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  Figure 1 External Fixator with saw guide 
 
 
 
   
  Figure 2 Representative x-ray images with 40, 70 and 100% stiffness external  
   fixator after 9 days, 2  and 3 weeks of treatment with rhBMP-2. 
 
 
 
 
 
